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ABSTRACT 
Studies in Peptide Synthesis Towards the Lanthionine 
Analog of Des-N-Tetramethyl Triostin A 
by 
Ganesh Devdas Kini, Doctor of Philosophy 
Utah State University, 1983 
Major Professor: Richard K. Olsen 
Department: Chemistry 
viii 
Studies have been carried out towards the synthesis of bicyclic 
octadidepsipeptide lanthionine ~' an analog of des-N-tetramethyl 
triostin A. Starting with a symmetrical lanthionine unit 1_ (R1 , R3 = 
Me; R2 , R4 = t-butyloxycarbonyl), synthesized from the corresponding 
cystine by contraction with hexaethylphosphorus triamide, linear 
octadidepsipeptides 29 and 32 were synthesized. 
R2NH y COOR1 Qxc-D-Ser-Ala-Ala-Val I 
s s 
~ I R4NH COOR3 Val+Ala+Ala+Val+Ser-D+-Qxc 
2_, Jj_, 80 4 
ix 
Z-D-Ser-OBpa Boc-:/Ala-Vall Z-D-Ser-Ala-OTce :o/Ala-Val l 
L Val+Al;:-'Ala-Boc BpaO-Ser-D+Z lVal-Al.-::.'oc TceO-Ala+Ser-D+Z 
29 32 
Attempted cyclizations of 29 and 32 to the bicyclic octapeptide 
were unsuccessful. 
The failure of the symmetrical approach to ~ prompted the 
synthesis of an unsymmetrical lanthionine unit with appropriate 
compatible protecting groups. Attempts to synthesize unsymmetrical 
lanthionines by nucleophilic displacement on N-benzyloxycarbonyl-S-
chloro-L-alanine and appropriate a-activated serine derivatives with 
the thiol function of L-cysteine were unsuccessful. L-valine as the C-
terminal amino acid of the a-activated serine was found to sterically 
hinder the nucleophilic displacement with the thiol, since the 
displacement could be effected when glycine was present in lieu of 
valine. 
The reaction of thiolsulfinate with cysteine led to an 
unsymmetrical cystine which was then contracted with 
hexaethylphosphorus triamide to yield the corresponding lanthionines. 
The synthesis of unsymmetrical lanthionines ?.!:... (R1 = t-butyl, R2 = t-
butyloxycarbonyl, R3 = ethyl, R4 = benzyloxycarbonyl) and~ (R 1 = t-
butyl, R2 2,2,2-trichloroethyloxycarbonyl, ethyl, 
benzyloxycarbonyl) has been accomplished. Lanthionines 76 and 80 each 
have four different protectings on the amino and carboxyl functions. 
These can be selectively removed in the right sequence for a proposed 
X 
synthesis of !:!_. further studies towards the synthesis of i, as 
proposed, were not pursued. 
(115 pages) 
INTRODUCTION 
The quinoxaline antibiotics are a class of compounds, 
characteristic of which is the presence of one or more quinoxaline 
chromophores. They are produced by several species of streptomycetes. 
Isolated and reported independently by Carter et al. 1 and Ueda et al. 2 
in 1954, these are a group of peptide antibiotics that possess unusual 
bicyclic structures. In 1961, the existence of two families of quin-
oxaline antibiotics, the quinomycins and the triostins, was reported. 3 •4 
The structures of triostin A (!) and echinomycin (_~) are as shown. 
Both are octadidepsipeptides, each composed of two D-serine, two L-
alanine, two N-methyl-L-valine and two N-methyl-L-cysteine units. The 
carboxyls of the N-methyl-L-valine units form two ester bonds, called 
depsipeptide bonds in peptide terminology, with the respective 
hydroxyls of the D-serine units. To the amine nitrogen of each D-
serine unit is attached a quinoxaline-2-carbonyl unit. 
The two families of antibiotics differ, however, in the central 
bridging of the bicyclic structure. Triostin A has a disulfide linkage 
between the two N-methyl-L-cysteine units. Hence, it is a symmetrical 
molecule with a c2 axis of rotation passing through the disulfide bond. 
Echinomycin, on the other hand, has a unique and hitherto unknown 
dithioacetal linkage in lieu of the disulfide bridge in triostin A. 
Consequently, it lacks the element of symmetry present in the triostin 
A molecule. 
Echinomycin, also known as quinomycin A, is produced by several 
species of streptomyces, while triostin A is produced only by 
Triostin A 
1 
. ( uinornycin A) Echinornycin q 
2 
2 
Streptomyces aureus. The quinoxaline antibiotics are of considerable 
interest because of their potent biological activity, which has been 
reviewed by Katagiri et al. 5 They are powerful antibiotics exhibiting 
antiviral, antimicrobial and cytotoxic activity. Their biological 
significance was noticed in 1955, when antitumor activity was first 
demonstrated. 6 A mixture of triostin A and triostin Chas been shown to 
be particularly effective against the mouse tumor strain, Mecca 
lymphoma. While the quinoxalines are known to show activity against a 
fairly broad spectrum of gram-positive, acid fast and anaerobic 
bacteria, their activity towards gram-negative bacteria and fungi is 
insignificant. 3 , 4 
The antibiotics have also been found to be active towards 
mycoplasma, 7 polio virus infection in mice, 8 and protozoa. 2 , 9 That 
they inhibit multiplication of bacteriophages has a lso been reported.lo 
Studies were carried out by Katagiri and Sugivra 11 and Matsuura, 12 
to determine the a ntitumor activity exhibited by som e of the 
quino xalines against several tumor systems in mice, rats, hamsters and 
c hickens. These studies indicated quinoxaline C to be the most 
therapeutically active. Another important aspect found from these 
studies was the fact that minor variations in structure within the 
quinoxalines resulted in significantly different antitumour activity. 
Echinomycin is now in the first phase of preclinical evaluation by the 
National Cancer Institute. 13 Olsen 14 has recently compiled a review of 
the quinoxaline group of antibiotics. 
The biological activity of the quinoxalines has aroused 
considerable interest in their possible clinical uses as also in their 
mode of biological action. First clues to their possible mode of 
3 
4 
action were provided by their cytotoxic response. Poisoned cell 
strains, upon staining, showed the aggregation of chromatin and 
d . . f h 1 . lS ispersion o t e nuc ei . 
quinoxaline antibiotics. 
This effect was common to all of the 
Waring et ai. 16 , 17 •18 •19 proposed the 
mechanism of activity to be direct interaction with DNA 
(deoxyribonucleic acid). The hypothesis was that the two quinoxaline-
2-carbonyl units are positioned parallel to each other and in a plane 
perpendicular to the peptide backbone. When they point in the same 
direction, the molecule resembles a staple. The staple-shaped molecule 
binds by inserting both the quinoxaline residues between different sets 
of base pairs on the DNA molecule, thereby inhibiting RNA synthesis. 
This unusual form of binding, termed "bifunctional intercalation" has 
been thoroughly studied and supported by binding data, 16 , 17 X-ray 
crystallographic data 19 and solution conformation studies. 2O 
The biological properties and the unusual mode of activity of the 
quino xaline antibiotics together have generated considerable interest 
i n the total chemical synthesis of these compounds as well as 
a nalogs. The first total synthesis of a quinoxaline antibiotic, 
triostin A was accomplished by Olsen and Chakravarty. 15 Olsen and 
coworkers 21 also synthesised the first biologically active analog, des-
N-tetramethyltriostin A. This synthetic analog, with the acronym 
TANDEM, differs from the naturally occuring antibiotic triostin A by 
the absence of the four N-methyl groups on the two cysteine and two 
valine residues (structure 2_). 
TANDEM [Des-N-Tetrarnethyl Triostin A] 
3 
The binding properties of TANDEM have turned out to be very 
unique. TANDEM exhibits a high degree of binding specificity for DNA 
with alternating sequences of adenine and thymine (poly dA-dT), as 
against the low specificity for poly (dG-dC). 16 , 17 Interestingly, the 
other naturally occurring quinoxaline antibiotics show the opposite 
sequence specificity in their binding to DNA. Waring 22 has recently 
reviewed the sequence selective binding to DNA of echinomycin, triostin 
A and related quinoxaline antibiotics in relation to their structure. 
The research presented in this thesis deals with studies towards 
the synthesis of another analog of the quinoxaline antibiotics, the 
lanthionine analog of des-N-tetramethyl trisotin A (structure 4). 
5 
Lanthionine Analogue of TANDEM 
4 
The interest in the synthesis of this molecule is two fold. One, 
the approach is to start with a lanthionine unit and develop a peptide 
synthesis, which could then be applied to a preformed S-
methylthiolanthionine, structure 5. Compound 5 is the central bridging 
5 
moiety of echinomycin l• This mixed dithioacetal has, as yet, not 
been synthesised, and its chemical properties, like stability 
to reaction conditions, have not been documented. In the previously 
reported synthesis of TANDEM 21 the cyclic octapeptide is 
first synthesized with the formation of the disulfide bridge being the 
6 
7 
penultimate step in the total synthesis. The approach here is exactly 
the opposite, to start with the central sulfur containing unit and 
develop a synthesis around it. 
The second aspect of interest in this study is the possible 
manifestation of the binding properties of the lanthionine analog. 
TANDEM, which differs from naturally occuring triostin A by the absence 
of four N-methyl groups, shows opposite sequence specificity in binding 
to DNA as compared to triostin A. The lanthionine analog would have 
its central bridge shortened by one sulfur atom compared to triostin A, 
but would exist with the same number of atoms in the bridging group as 
in echinomycin. Hence, it would be of considerable interest to study 
the binding properties of the lanthionine analog in comparison with 
TANDEM itself, as also with triostin A and echinomycin. 
Attempts to synthesize::_ starting with a symmetrical lanthionine 
unit were unsuccessful. Hence, the logical alternative was to start 
with a suitably protected unsymmetrical lanthionine. The results of 
these studies will be presented herewith. 
LITERATURE REVIEW 
The structure and conformation of 
echinomycin and triostin ~ 
Prelog and coworkers 23 reported the first structure elucidation 
for a quinoxaline antibiotic. From the data available at that time, 
they proposed the following structure~ for echinomycin. The sulphur 
unit was proposed to exist as a 1,4-dithiane ring system. 
CH3 CH3 
"" I O N CH3 CH3 C8:3 CH :l H I I I I -ro N C - N- CH- C - N- CH-C - N- C - C - N - CH- C 
II I II H II / I II I 
0 0 0 S 0 
CH2 / CH 0 
I CH2 / 2 I 
0 0 l s O O CH2 0 I II / II H II I II 
C - CH - N - C - C - N - C - CH- N - C - CH - N - C N 
0~ I I I l H 1~ 
CH CH3 CH3 CH3 :-..N~ 
/'-. 
CH3 CH3 
6 
In 1975, Williams and coworkers, 24 and Martin and coworkers 25 
independently reported their spectroscopic studies on the structure of 
echinomycin. After consideration of their evidence based on 1H and 13c 
nuclear magnetic resonance data, the hitherto accepted 1,4-dithiane 
cross link was revised to a dithioacetal cross link. Structure 2 is 
now the accepted structure for echinomycin. As seen in~. there exists 
a chiral center within the cross link at the B-carbon of the lantionine 
unit. The configuration at the chiral carbon, however, has not yet 
8 
been established. The revision in the structure of echinomycin is 
schematically shown below, with the rest of the molecule remaining the 
same. 
s 
"'-/ 
--CH 2 
""C / 
CH - S 
"/ 2 "' / C C CH-CH 
/ /" CH2 -s /I / " H CH3 - S 
old revised 
Otsuka and Shoji 26 carried out structural studies on the triostins 
and assigned structure to triostin C. Among the triostins produced by 
Steptomyces aureus, triostin C happens to be the major isomer . After 
further studies on the minor components of the quinoxaline antibioties, 
Otsuka et al. 2 7 assigned structure to triostin A in 1967. 
There are a number of recent reports on the conformations of 
triostin, echinomycin and the quinoxaline antibiotics in 
generai. 28 , 29 , 3O, 31 Ughetto and Waring, 32 have reported theoretical 
studies carried out on the conformations of echinomycin. From these 
studies, it was concluded that conformational changes are restricted by 
the dithioacetal linkage, and that the two quinoxaline chromophores 
orient themselves on the same side of the peptide ring in the 
conformation that is most stable. Williamson and Williams 31 have come 
to the same conclusion for the solution conformation of echinomycin, 
after analysis of nmr data using the nuclear Overh a user effect, Feeney 
and coworkers 33 have published proton nmr data supporting Waring and 
Ughetto's conclusion . 
9 
10 
Williams and coworkers, 34 and Kawano and coworkers 35 have reported 
studies on the solution conformation of triostin A. They found 
triostin A to exist in two symmetrical conformations in chloroform 
solution. From the analysis of their nmr data, Williams and 
coworkers 20 concluded that the quinoxaline chromophores, like in 
echinomycin, were oriented on the same side of the peptide backbone. 
Olsen, 14 in his review on the quinoxaline antibiotics, has discussed 
the conformational analysis for triostin and echinomycin in detail. 
Synthesis£!. triostin and echinomycin 
There have been relatively few reports on synthetic studies of the 
quinoxaline antibiotics. To date, the total synthesis of echinomycin 
has not been reported. 
Olsen and coworkers 36 were the first to synthesize a biologically 
active analog of a naturally occurring quinoxaline antibiotic. This 
analog of triostin A differed from the naturally occuring antibiotic by 
the absence of four N-methyl groups on the two valine and two cysteine 
residues. Hence, it was christened des-N-tetramethyltriostin A, with 
the acronym TANDEM (structure l). 
according to Scheme 1. 
The synthesis was carried out 
The linear tetrapeptide ~, which constitutes one half of the 
symmetrical molecule TANDEM l, was a key intermediate. Tetrapeptides 2_ 
and lQ_, both derived from~, were then coupled to give the linear 
octapeptide g. This is an example of how Olsen and coworkers took 
advantage of the symmetry in the molecule to facilitate its synthesis. 
Other salient features of this synthesis were the tactful use of 
protecting groups. The 2,2,2-trichloroethyl ester 37 protecting group 
at the alanine residue in 1:l_ can be selectively hydrolyzed under 
Z-D-Ser-Ala-OTce 
Boe-Val _J 
7 
d, a 
Acrn 
a, b, c 
Z-D-Ser-Ala-OR 
Y-Cys-ValJ 
I 
Acrn 
9: R = H, Y = Boe 
10: R = Tee, Y = H 
I 
Z-D-Ser-Ala-Cys-Val 7 
Boc-Cys-Val J Z-D-Ser-Ala-OTce 
I 
Acrn 
11 
Acm 
I g, h, i 
Z-D-Ser-Ala-Cys-Val 7 
Lval+Cys+-Ala+-D-Ser Z 
I 
Acm 
12 
11 
Z-D-Ser-Ala-OTce 
Boc-Cys-Valj 
I 
Acrn 
8 
b, e 
d, a, f 
Y-D-Ser-Ala-Cys-Val 7 
Lva1+-cts+-A1a+-D-Ser Y 
13: Y=Z 
3: Y = Qxc 
(a) TFA; (b) NaHC03; (c) Boc-Cys(Acm)-OH, EDC, ROBT, THF; (d) Zn, 
aq 0 ACOH; (e) EDC, ROBT, THF; (f) DCC, N-methylrnorpholine 1-hydroxy 
succimide, THF; (g) lz, MeOH; (h) HBr, AcOH; (i) Et 3N, DMF, QxcCl , Abbreviations: Boe= tert-butyloxycarbonyl, Acm = acetamidomethyl, 
EDC = l-ethyl-3-(3-dimethylaminopropyl)carbodiimide·HCl, ROBT = N-
hydroxybenzotrizote, THF = tetrahydrofuran, DMF = N,N-dimethyl-
formarnide, Qxc = quinoxaline-2-carbonyl, Z= benzyloxycarbonyl. 
Sch eme 1. 
12 
reductive conditions with zinc and acetic acid without affecting the 
depsipeptide ester bond. The acetamidomethyl group 38 , 39 was used to 
protect the cysteine thiol functions. This group undergoes oxidative 
cleavage upon treatment with iodine in methanol with the simultaneous 
formation of the disulfide bond 40 (11_ to _!l). 
The amino groups of the two serines were protected with the 
benzyloxycarbonyl group (Z group), while the N-terminals of the 
cysteine residues were protected with the tert-butyloxycarbonyl (Boe) 
group. 41 The latter can be selectively cleaved with trifluoroacetic 
acid 42 without affecting the Z-groups and the depsipeptide ester bonds. 
The use of l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in 
coupling reactions facilitates the workup, as compared to that with the 
use of N,N'-dicyclohexylcarbodiimide. In the latter case, one of the 
products of the reaction, N,N'-dicyclohexylurea, is insoluble and 
precipitates out of the solvents normally used in peptide couplings, 
like methylene chloride or pyridine. This product has to be removed by 
repeated filtration. When EDC is used, the urea formed is water 
soluble, and thus can be removed from the reaction mixture by washing 
the organic phase with water. The depsipeptide bond in J_ was formed by 
the use of N,N'-dicyclohexylcarbodiimide in anhyd pyridine. 43 Compound 
13 was converted to 1_ by acidolysis of the benzyloxycarbonyl group 
using HBr in acetic acid followed by acylation 44 with 2-quinoxaloyl 
chloride in dimethylformamide. 
The synthesis of the des-N-tetramethyl analog was prompted by 
the fact that N-methylamino acids are generally not commercially 
available in protected form as are their naturally occurring 
counterparts. 
13 
Olsen and coworkers 45 also reported another approach to the 
synthesis of des-N-tetramethyltriostin A. Octapeptide g was 
synthesized, the cyclization being effected by the coupling of the C-
terminal of serine with the N-terminal of alanine. The linear 
octapeptide synthesized had the following structure, 
Boc-Ala-c 1s-Val l Z-D-Ser-OBpa 
Acm Acm J 
Z-DSer-Ala-Cts-Val 
Bpa: p-bromophenacyl 
The p-bromophenacyl ester 46 protecting group (Bpa) was used and 
found to be more suitable than the trichloroethyl ester group. 
Chakravarty and Olsen 15 accomplished the total synthesis of 
triostin A, using the strategy and methods developed for the synthesis 
of TANDEM, with a few, but significant, modifications. A new 
protecting group, the benzamidomethyl (Barn) group was developed 47 for 
the protection of the thiol functions of the N-methyl-1-cysteine 
residues. This group was found to be much better than the 
acetamidomethyl used in the synthesis of TANDEM. Tetrapeptide __!i, 
again the key intermediate, upon treatment with zinc and acetic acid to 
synthesize 1:2_, did not undergo a clean transformation, and starting 
material 14 was left behind. 
Z-D-Ser-Ala-OR 
Boc-MeCys-MeVal _J 
I 
Barn 
14: R Tee 
15: R = H 
Z-D-Ser-Ala-OR 
H-MeCys-MeVal J 
I 
Barn 
16: R = Tee 
IT: R = H (as trifluoroacetate salt) 
Barn 
I 
Z-D-Ser-Ala-MeCys-MeVal 7 
Boc-MeCys-MeVal J Z-D-Ser-Ala-OR 
I Barn 
18: R = Tee 
19: R = H 
14 
The problem of incomplete removal of the trichloroethyl ester 
function was found to be more predominant in the synthesis of l2_ from 
18. Conditions more vigorous than normally used for the removal of the 
trichloroethyl ester function resulted in the destruction of 18 to form 
a complex mixture of products. Hence, this pathway to the cyclic 
octapeptide had to be modified. 
Linear octadepsipeptide 19 was synthesized in good yield by 
coupling 17 with the mixed anhydride of 15. 
Barn 
I 
Z-D-Ser-Ala-MeCys-MeVall 
tMeVal+-Cys +-Ala+D-Ser+Z 
I 
Barn 
20 
15 
Cyclic octapeptide lQ_ was synthesized from ..!:2_, after deblocking 
the amino group of the N-methylcysteine, followed by cyclization in THF 
solution with l-ethyl-3-(3-dimethylaminopropyl)carbodiimide and N-
hydroxysuccimide.48 During the course of this synthesis, Chakravarty 
and Olsen observed that, in general, N-methylamino acid peptides were 
oils as compared to their naturally occurring counterparts. 
Shin and coworkers 49 , as part of their studies towards the total 
synthesis of triostin A, synthesized the tetradepsipeptides _?_!_, ~' ~' 
and 24. 
Z-MeCys (Bzl )-Me Val 7 Qxc-D-Ser-Ala-OH 
21 
Z-MeVal 7 Qxc-D-Ser-Ala-MeCys(Bzl)-OH 
23 
Bpoc-MeCys(Bzl)-MeVall 
Qxc-D-Ser-Ala-OtBu 
22 
Bpoc-MeVal 1 Qxc-D-Ser-Ala-MeCys(Bzl)-OtBu 
24 
Bpoc: 
Qxc: 
2-(4-biphenyl)-2-propoxycarbonyl 
quinoxaline-2-carbonyl 
In the design of their synthesis, the symmetry of the triostin A 
molecule was considered. Cyclization by the formation of the 
depsipeptide ester bonds was not considered, since the low reactivity 
of the serine hydroxyl would necessitate the activation of the 
appropriate carboxyl group 5 0 to an extent that side reactions and 
racemization would be facilitated. Hence, the cyclization had to be 
effected by the formation of a peptide bond. Each of the peptides_?_!_, 
16 
~, 11_ and~ represent one half of the triostin A molecule. The 
approach was to attempt synthesis of triostin A via~ and~ or~ and 
J:.!!.... in two separate systems. Attempted deprotection of~ to yield the 
free amine resulted in the formation of dipeptide ~, and a product 
identified as cyclo [-MeCys(Bzl)-MeVal-]. These were inferred to be 
products of intramolecular aminolysis. Since then, Shin and 
coworkers 51 have reported the total synthesis of triostin A in 1980. 
Qxc-D-Ser-Ala-OtBu 
25 
The above workers also developed a new method for the introduction 
of the quinoxaline-2-carbonyl group on the serine nitrogen by the use 
of the p-nitrophenyl ester of quinoxaline-2-carboxylic acid. An 
interesting observation was the formation of the depsipeptide bond in 
peptide 26 by the use of N,N'-carbonyldiimidazole 52 or 2,2'-dimethyl-
Bpoc-MeVal 1 
Qxc-D-Ser-Ala-OtBu 
26 
l,l'-carbonyldiimidazole 53 even though in relatively low yield. This 
is contrary to the findings of Olsen and coworkers 43 who found these 
methods unsuccessful in the formation of depsipeptide bonds. 
Olsen 54 reported studies on the introducton of the quinoxaline-2-
carbonyl moiety in amino acids, tripeptides and tetrapeptides. The 
Merrifield Solid Phase method 55 was found to give satisfactory results 
as compared to standard methods of peptide coupling. 
17 
Cheng and coworkers 44 investigated synthetic routes to bis-
quinoxaloyl derivatives containing peptide linkages. 
Olsen and coworkers 43 synthesized cyclic tetradepsipeptides as 
models for one portion of the bicyclic octadepsipeptide echinomycin. 
Rt-Ser-Ala-NH 
L (R') Val+C ~ 
II 
0 
R: carbobenzoxy, quinoxaline-2-carbonyl 
R': -(CHz)4-
The depsipeptide bond formation was accomplished by the use of an 
excess of the carboxylic acid with N,N '-dicyclohexylcarbodiimide in 
pyridine solution. The mixed anhydride and carbonyldiimidazole methods 
were found to be unsatisfactory. 
Synthesis of lanthionines 
The amino acid lanthionine has the following structure. This 
NHz 
I 
HOOC-C-CHz-S-CHz-C-COOH 
I I 
NHz 
I 
H H 
amino acid, S-amino-S-carboxyethyl sulfide, was first reported by Horn 
and coworkers 56 , 57 to be formed by the action of sodium carbonate on 
wool and other proteins. 
Lanthionine is a special case of a sulfide, hence an unsymmetrical 
lanthionine would be a special case of an unsymmetrical sulfide. There 
18 
have been several methods reported for the synthesis of unsymmetrical 
sulfides. 58 - 62 However, these are not amenable to peptide synthesis 
and to the synthesis of lanthionines. The methods reported for the 
synthesis of symmetrical and unsymmetrical lanthionines and cysteinyl 
peptides will be discussed. 
Brown and du Vigneaud 63 reported the first synthesis of 
lanthionine by the action of L-cysteine on dl-a-amino-B-
chloropropionic acid in strongly alkaline base. 
NH2-CH-CH2-SH + I 
COOR 
+ 
Cl-CHz-CH-NH3Cl 
I 
COOR 
NH2-CH-CHz-S-CH2-CH-NHz 
I l 
COOR COOR 
Base 
(Aq KOH)> 
Jacobsen and coworkers 64 reported, as early as in 1955, the use of 
phosphines to contract disulfides. 
P(OEt)3 + EtSSEt ~ [EtS+- ] ~ EtSPO(OEt)z + EtSEt 
EtSP(OEt) 3 
In 1971, Harpp and Gleason 65 utilized alkylamino phosphines to 
effect selective removal of a sulfur from appropriate cystine 
derivatives to yield symmetrical lanthionines. 
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ZNHYCOOMe ZNHY COOMe 
GHz GHz 
I (EtzN )3P I 
s s + (EtzN) 3P = s 
I I 
s GHz 
I ~ 
GHz ZNH COOMe 
A 
ZNH COOMe 
Z: C6H5CHzOOC-
The method of Harpp and Gleason, however, was reported 65 not to be 
useful for the synthesis of unsymmetrical lanthionines. This reaction 
will be discussed in detail later. 
Photaki and coworkers 66 synthesized an unsymmetrical lanthionine 
by making use of the steric bulk of the triphenylmethyl group (trityl). 
A lanthionine diester, with a trityl group on one of the a-amino 
functions, upon hydrolysis, yields a mono-acid, the trityl group 
shielding the ester on the a-carboxyl from hydrolysis. Photaki's 
reaction sequence was as follows. 
CHzSH 
I 
CHz-Cl 
I 
ZNH-CH-COOH + HzN-CH-COOH 
KOH-HzO _c\\-i.:' 
ZNH-CH-CHz-Sf-CH-NHz 
I " I 
COOR COOR 
SOClz/MeOH 
+ _ Ph3CCl, Et3N 
ZNH-CH-CHz-S-CHz-CH-NH3Cl 
I I 
ZNH-CH-CHz-S-CHz-CH-NHCPh3 
I I 
COO Me COO Me COO Me COO Me 
NaOH 
ZNHCH-CHz-S-CHz-CH-NHCPh3 
Acetone/HzO I I 
COOR COOMe 
20 
As will be discussed later, attempts to synthesize a lanthionine 
using this method were unsuccessful. 
Wilchek and coworkers 67 reported the synthesis of optically active 
L-cysteine peptides in high yields by the reaction of thio reagents 
with peptides containing a S-chloroalanine unit. The thio reagents 
used included thioacetate, thiobenzoate and benzyl mercaptide. N,N-
dimethylformamide or ethyl acetate were used as solvents. 
CH2Cl 
l RS 
ZNH-CH-CONHCH2COOC2H5 ) 
CH2SR 
I 
ZNH-CH-CONHCH2COOC2H5 
While this method worked well for the synthesis of some cysteinyl 
peptides, it could not be used on systems with an ester function on the 
carbon S- to the carbon with the chlorine. 
In a stri .kingly similar manner, Wilchek and coworkers 68 
synthesized cysteinyl peptides from peptides with an L-serine residue. 
The thioacetate anion effected an SN2 displacement on 0-p-toluene-
sulfonyl-L-serine peptides in N,N-dimethylformamide or aqueous media to 
quantitatively yield optically active S-acetyl-L-cysteine peptides. 
CH20Ts 
I 
ZNH-CH-CONHCH2COOC2H5 
DMF 
CH2SCOCH3 
I 
ZNH-CH-CONHCH2COOC2H5 + TsONa 
21 
However, an ester function 8 to the carbon with the tosylate group led 
to racemic product. 
OTs 
I 
Z-Ser-OCH 3 
SCOCH3 
I 
Z-Cys-OCH3 
DMF 
Ser: serine 
Cys: cysteine 
The ester function promotes elimination to yield a dehydroalanine 
ester. The mercaptide anion then adds to the a,8-unsaturated ester in 
Michael fashion to yield racemic product. This is one of the 
CH2-0Ts 
I 
Z-NH-CH-COOCH3 > 
CH2 
II 
Z-NH-C-COOCH3 
dehydroalanine derivative 
CH2SCOCH3 
I 
Z-NH-CH-COOCH3 
limitations of this method. Results on the attempted synthesis of some 
cysteinyl peptides using this method will be presented and discussed 
later. 
Nakajima and coworkers 69 recently reported the first example of 
ring opening by thiols to yield lanthionine. The aziridine ring, upon 
reaction with thiols under Lewis acid catalyzed conditions , yielded the 
corresponding lanthionines. 
R2 
I 
/CH 
H-N I 
........._CH 
I 
COOBzl 
Synthesis of unsymmetrical cystine 
containing peptides 
Z-Cl 
R2 
I 
/CH 
Z-N I 
"-cH 
I 
COOBzl 
ZNH COOBzl y 
R -CH 
2 I 
Alkyl 
H, CH3 
s 
I 
Rl 
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As in the case of lanthionines, several methods have been reported 
for the synthesis of unsymmetrical disulfides, 70-BO where as relatively 
few are available for the synthesis of cystine containing peptides. 
In 197 3, Kamber 81 synthesized various fragments of insulin 
containing a disulfide bridge. The fragmentation of sulfenyl thio 
carbonate with a thiol unit can be applied to the synthesis of 
unsymmetrical cystine peptides. 
Scm 
I 
Boc-Cys-Asn-OtBu + Boc-Cys(H)-Gly--Glu(OtBu) 2 
> 
Scm: 
Boe: 
tBu: 
Boc-Cys-Asn-OtBu 
I 
Boc-Val-Cys-Gly--Gly(OtBu)2 
0 
II 
-S-C--OCH3 
tert-butyloxycarbonyl 
tert-butyl 
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Kamber also reported 82 the synthesis of cystine peptides by the 
reaction of S-acetamidomethyl cysteine peptides with iodine. Using 
this method, Kamber was able to synthesize cyclo-L-cystine, which, at 
that time, was unknown. 
0 
II 
CH3CNHCHz 
I 
s 
I 
CHz 
I 
BocNHCHCOOH 
+ 
0 
II 
CHzNHCCH3 
I 
s 
I 
CHz 
I 
HzN-CH-COOCH3 
CHz-NH-COCH3 
I 
s 
I 
CHz CHz 
I I 
BocNHCH-CO-NH-CH-COOCH3 
s 
I 
---S 
I 
CHz CHz 
I I 
BocNHCH -CO -NH -CH -COOCH 3
cyclo-L-cystine derivative 
DCC: N,N'-dicyclohexylcarbodiimide 
DCC 
Iz 
The reaction of L-cysteine esters with S-carbomethoxy derivatives 
to yield L-cysteine containing disulfides has been studied by Kemp and 
coworkers. 83 
24 
Cl'CC:'Scm 
0 
+ Boc-L-Cys-OMe 
(i) HCl, dioxane 
(ii) NaHC03 
I 
Z-Ala 
Cl~ ~ O S- S rCOOMe 
I NH2 
Z-Ala 
Hiskey and Ward 84 reported their studies on the synthesis of 
cystine peptides using sulfenyl thiocyanates. They applied this method 
to the synthesis of numerous cystine peptides with different amino 
acids, and observed no significant side reactions. 
R-S-X 
[R-S-SCN] 
+ 
R'-S-X R-S-S-R' 
+ 
X-SCN X-SCN 
Hiskey and coworkers 85 also reported the synthesis of 
unsymmetrical cystine peptides using the S-carbomethyoxy sulfenyl group 
as a labile intermediate for the selective conversion of a cysteine 
residue to a cystine. 
Aero Scm 
I I 
Boc-Cys-Asn-OtBu Boc-Cys-Asn-OtBu 
Tr Scm 
I 
Boc-Cys-Asn-OtBu Boc-Cys-Asn-OtBu 
Scm 
I 
Boc-Cys-Asn-OtBu 
Boc-Val-Cys-Gly-Glu(OtBu) 2 
Boc-Cys-Asn-OtBu 
I 
Boc-Val-Cys-Gly-Glu(OtBu)z 
Acm: acetamidomethyl 
Tr: triphenylmethyl 
Scm: S-carbomethoxy 
tBu: tert-butyl 
25 
The reaction of thiolsulfinates with cysteine to yield 
unsymmetrical disulfides containing cysteine has been reported. 86 
0 
i 
R-S-S-R + 
CH2-SH 
I 
CH-COOH 
I 
NHz 
COOH 
I 
R-S-S-CH 2-CH I 
NHz 
The method used for the synthesis of unsymmetrical lanthionines in 
this thesis is an approach based upon mechanistic consideration of the 
disulfide contraction reported by Harpp and Gleason. 65 
g' 
An extension of the method of Schober1,ifi involving the addition 
of a cysteine to a cystine sulfoxide, resulted in an unsymmetrical 
cystine. 
0 
i R'SH 
R-S-S-R R-S-S-R' 
26 
This unsymmetrical cystine was then selectively desulfurized with 
hexaethyl phosphorus triamide, used either in stoichiometric amount or 
in excess. These details are discussed later. 
R-S-S-R I R-S-R' + (EtzN)3P = S 
Benzene 
27 
RESULTS AND DISCUSSION 
The structure of the target molecule outlined for synthesis, the 
lanthionine analog of TANDEM,is as shown below, structure 4. 
Qxc-D-Ser-Ala-Ar-V•l l 
l Val+Aia<-Ala<-Ser-D Qxc 
4 
~ is a symmetrical bicyclic octadidepsipeptide, with a c2 axis of 
symmetry through the sulphur atom. 4 differs from TANDEM in that the 
central bridging unit has one sulfur atom as compared to two in TANDEM, 
with the rest of the molecule being the same for both 4 and TANDEM. 
The central bridging unit of~ is a lanthionine unit~-
5: R = H 
5a: R = SCH3 
In the previously reported synthesis of triostin A and TANDEM, the 
cyclic octapeptide is synthesized first and the central bridging unit 
incorporated in the penultimate step of the total synthesis. The 
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approach presented in this thesis is to start with a suitably protected 
lanthionine unit 5 and develop a peptide synthesis about the 
lanthionine unit. As part of a continuing program towards the total 
synthesis of echinomycin, the methods developed for 1_ could then be 
applied to a preformed S-methylthio lanthionine unit Sa, which is the 
central bridging unit in echinomycin, thus leading to echinomycin. 
Hence the studies towards the synthesis of 4 would provide a model for 
the total synthesis of echinomycin. 
The second aspect of interest in the synthesis of~ is the 
possible manifestation of the binding properties of~ to DNA. As 
mentioned before, TANDEM differs from the naturally occurring triostin 
A by the absence of four N-methyl groups on the cysteine and valine 
residues. TANDEM, however, exhibits opposite sequence specificity in 
its binding to DNA as compared to triostin A. It has been established 
that small changes in structure lead to significant difference in 
activity among the quinoxaline antibiotics. Hence, it would be 
interesting to compare the binding properties of 4 with TANDEM and 
triostin A. The central bridging unit of 4 has the same number of 
atoms as that in echinomycin. Thus, a comparison of the binding 
properties of~ to those of echinomycin would be of considerable 
interest and biological significance. 
The symmetry of the target molecule~ prompted the design of the 
total synthesis of 4 starting with a symmetrical lanthionine. 
Attempted cyclization of the octapeptide synthesized, however, was 
unsuccessful. This led to the logical alternative to start the 
synthesis with an unsymmetrical lanthionine with appropriate protecting 
groups that would permit the cyclization leading to the bicyclic 
29 
6ctapeptide i to be effected in two separate steps, the first one 
leading to one half of the bicyclic system, with the second leading to 
bicyclic octapeptide i• 
The synthesis of a suitable lanthionine unit with four different 
and compatible protecting groups was found to be a challenging one. 
Different approaches to the synthesis of lanthionines had to be 
pursued. Hence, while the synthesis of two suitably protected 
lanthionines was accomplished, the subsequent syntheses leading to 
octapeptide lanthionine i as proposed, were not carried out. 
Thus, a synthesis starting with a symmetrical lanthionine unit was 
designed, and as shown in Scheme 2. 
Preparation of lanthionine 27 from 
N,N'-di-t-butyloxycarbonyl-L-cystine 
dimethyl ester 
N,N'-Di-t-butyloxycarbonyl-1-cystine dimethyl ester 1.§_ was 
prepared by the reaction of di-t-butyl-dicarbonate 87 with commercially 
available L-cystine dimethyl ester dihydrochloride, in N,N-
dimethylformamide solution in the presence of triethylamine. This 
method of introducing the Boe-protecting group is more convenient than 
the previously used method using t-butyloxycarbonyl azide, as the 
latter has explosive tendencies. This method is also known to give 
higher yields. Compound 2---8~ __, upon treatment with 
hexaethylphosphorus triarnide in benzene solution, underwent a clean 
disulfide contraction to yield lanthionine 27 in 80% yield after 
chromatographic purification using the mplc with 20% acetone in hexane 
as the eluting solvent. 
Boc-Ala-OMe 
I 
s 
I 
s 
I 
Boc-Ala-OMe 
26 
(i) hydrolysis 
(ii) coupling with 
Z-D-Ser-OBpa 
H-Val_J 
(i) TFA 
(ii) coupling with 
Boe-Ala-OH 
deprotection 
Boc-Ala-OMe 
I 
s 
I 
Boc-Ala-OMe 
27 
Z-D-Ser-OBpa Boe-Ala-Val 7 
l / s / Z-D-Ser-OBpa Val+Ala-Boc 
28 
30 
Z-D-Ser-OBpa Boc~A/Ala-Vall 
LVal+Al:+Ala-Boc Z-D-Ser-OBpa 
29 
Z-D-Ser-OH H-Al:;la-Vall 
L V al +Ala+Ala-H HO+Ser -D+Z 
30 
cyclization 
Z-D-Ser-Ala-A!a-Vall 
l Val+Aia+Ala+Ser - D+Z 
31 
Scheme 2. 
31 
The 1H NMR of 27 was identical to that of 26 with one exception. 
The cystine methylenes in l§_ appear as a doublet at o 3.2, while those 
in Q appear as a doublet at 83.0. This is in accordance with the 
higher deshielding of the methylenes by two sulfur atoms in 26 as 
against one in ]:]_. In fact, this was the only way by which we 
differentiated l§_ and]:]_, other than elemental analysis, since they 
both have identical Rf values on tlc. It was observed that the 
conversion of~ to']]_ was essentially complete. A mixture of 26 and 
']]_ would not be separable by silica gel chromatography because of their 
identical Rf values. C, H, N and S analysis data for 27 were in 
satisfactory agreement with the calculated values, thus confirming the 
desulfurization. 
The mechanism of lanthionine 
contraction 
The mechanism of this reaction, reported by Harpp and Gleason, 65 
can be visualized as a two-step process. Step 1 is the nucleophilic 
attack of phosphorus on the sulfur, resulting in the formation of a 
positively charged phosphonium ion and a mercaptide anion. Step 2 is 
the attack of the mercaptide anion on the carbon a to the sulfur of the 
phosphonium ion, resulting in the formation of the lanthionine and 
phosphine sulphide. 
R 
~ 
CH2 + S-CH2-R 
cl + 
S- P(Et 2N) 3 
Synthesis of and cyclization studies 
of linear octapeptides l2._ and l?_ 
R-CH2-S-CH 2-R 
+ 
S=P(Et 2N) 3 
32 
Compound r!_ was hydrolyzed with sodium hydroxide in dioxane-water 
to yield the diacid in 86% yield. This diacid was coupled with 
didepsipeptide N-benzyloxycarbonyl-0-(N-Boc-L-valyl)-D-serine p-
bromophenacyl ester 2 to yield hexapeptide 28. 1H NMR spectrum of 28 
showed the characteristic absorption doublet at o 1.0 of the valine 
isopropyl methyls. An A2 B2 quartet at o 7.8 corresponding to the 
phenacyl aromatic was present. Elemental analysis data were in 
satisfactory agreement with the calculated values. 
Treatment of 28 with triflouroacetic acid, followed by coupling 
with N-t-butyloxycarbonyl-L-alanine led to~- The structure of 29 was 
confirmed by the presence of the absorption peaks by the alanine 
methyls at o 0.9 and satisfactory combustion analysis. The couplings 
to yield~ and l2._ were carried out in tetrahydrofuran using water 
soluble carbodiimide (EDC) and 1-hydroxybenzotriazole. 
Deprotection of the amino groups with triflouroacetic acid 
followed by reductive hydrolysis of the p-bromophenacyl ester groups 
with zinc and acetic acid led to octapeptide 30 with two free carboxyl 
and two free amino groups. 
There were two potential problems in the cyclization of 
octapeptide 1Q to yield l!_. One was intermolecular coupling, where 
33 
instead of cyclization, the product would be a mixture of polypeptides. 
This was minimized by performing the reaction under high dilution, 
which would facilitate only intramolecular coupling. The second 
potential problem was intramolecular coupling in the undesired mode, as 
illustrated below. 
Desired mode of coupling 
~ 
1 H HO-Ser-D-Z 
L Ala-Ala-Val J 
I 
s 
I 
1 val+-Ala+-Ala J 
Z-D-Ser-OH H ~
~------Ser-D-Z 
L Ala-Ala-Val J 
I 
s 
I I Val+-Ala+-Ala l 
Z-D-Ser ------~-
Undesired mode of coupling 
The undesired mode of coupling involves the formation of a 
thirteen membered ring as against a seventeen membered ring to give the 
desired product. Since a 17-membered ring formation is favored over a 
13-membered one, 88 it was presumed that the formation of the bicyclic 
octapeptide l!._ would be favored. The products of attempted coupling of 
lQ_ were compared to an authentic sample with a disulfide bridge instead 
of a monosulfide, as it was assumed that they would both have the same 
Rf values on tlc. Tlc analysis showed the product of reaction to be a 
complex mixture. Attempts to isolate 31 were unsuccessful. 
34 
Octapeptide 1_l was synthesized by coupling of lanthionine r!_, 
after hydrolysis, with a previously reported 21 tridepsipeptide N-
benzyloxycarbonyl-0-(L-valyl)-D-seryl-L-alanine 2,2,2-trichloroethyl 
ester. The coupling was carried out in THF with EDC and N-
hydroxysuccinimide. 
Boc-Ala-OMe 
I 
s 
I 
Boc-Ala-OMe 
(i) hydrolysis 
(ii) coupling with H-Val 1 
Z-D-Ser-Ala-OTce 
Z-D-Ser-Ala-OTce :o/Ala-Val 7 
L Val+Al:'Boc TceO-Ala<-D-Ser•Z 
deprotection 
32 
Z-D-Ser-Ala-OH S /Ala-Val 7 
LVal+A(.-H HO-Ala<-D-Ser-Z 
33 
Removal of the Boe-groups upon treatment of 32 with 
trifluoroacetic acid, followed by reductive cleavage of the 
trichloroethyl ester functions with zinc in acetic acid, led to 
octapeptide 12• Attempted cyclization of ll. to l!_ under conditions 
identical to those used in the cyclization of lQ_ to l!_ resulted in a 
complex mixture of products and l!_ could not be isolated. The 
cyclization of lQ_ to 31 involves amide bond formation between the C-
terminal of the serine and the corresponding N-terminal of the alanine 
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units. In the case of 11_, however, the amide bond would be formed 
between the C-terminal of the alanine moeity with the N-terminal of the 
lanthionine unit. Both modes of cyclization have been reported 21 , 45 in 
the synthesis of cyclic octadepsipeptides without the central sulfur 
unit. 
Studies on lanthionine contraction 
of tetrapeptide 34, hexapeptide 35, 
cycloctapeptide 13 and TANDEM --
In order to study the application of Harpp's method of disulfide 
contraction to other systems, tetrapeptide ~ was synthesized. N,N'-
di-t-butyloxycarbonyl-1-cystine was coupled with the methyl ester of L-
valine in pyridine using dicyclohexylcarbodiimide to yield 34. 
Boe-Ala-OH 
I 
s 
I 
s 
I 
Boe-Ala-OH 
+ H-Val-OMe 
DCC 
Pyridine 
Boc-Ala-Val-OMe 
I 
s 
I 
s 
I 
Boc-Ala-Val-OMe 
34 
DCC: dicyclohexylcarbodiimide 
1H NMR of 34 showed the characteristic absorption peak for the valine 
isopropyl methyls as a doublet at cS 1.0. 
Tetrapeptide ~ was treated with 1.2 eq of hexaethylphosphorus 
triamide in benzene solution. Upon purification of the reaction 
product on mplc, the corresponding lanthionine was obtained in 30% 
yield. The lanthionine showed the absorption peak of the cystine 
methylenes as a doublet at cS 3.0. C, H and N analysis were in 
agreement with the calculated values. 
Hexapeptide 35 was synthesized as shown below. 
Boe-Ala-OH 
I 
s 
I 
s 
I 
Boe-Ala-OH 
-+ 
+ 
TFAH-Val 7 
Z-D-Ser-OBPA 
Boc-Ata-Val 7 
S Z-D-Ser-OBpa 
I 
S Z-D-Ser-OBpa 
Boc-Aia-Val _J 
35 
NMM: N-methylmorpholine 
NMM 
EDC, ROBT, THF 
EDC: l-ethyl-3-(3-dimethylaminopropyl)carbodiimide-HCl 
ROBT: 1-hydroxybenzotriazole 
36 
The structure of 35 was established by 1H NMR data, which showed the 
a romatic protons of the p-bromophenacyl group resonating as an A2 B2 
quartet at o 7.8. The absorption of the aromatics of the 
benzyloxycarbonyl groups appeared as a sharp singlet at o 7.2. The 
valine isopropyl methyls resonated a doublet at o 1.0. Elemental 
analysis for C, H, and N were in agreement with the calculated values. 
Attempts to contract the hexapeptide 12_ to the corresponding 
lanthionine were unsuccessful. Analysis of the products of reaction 
after treatment of 12_ with hexethylphosphorus triamide indicated that 
the desired lanthionine was not obtained, and starting material was 
recovered. 
A contraction of the cyclic octapeptide Q shown below, which is a 
known intermediate prepared in the synthesis of TANDEM21 , was attempted 
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using the above contraction procedure. The products of reaction were 
separated and isolated by preparative tlc. 360MHz ¾I NMR spectral data 
Z-D-Ser-Ala-Ala-Val 
I 
s 
I 
s 
I 
Val-Ala+Ala+Ser D-Z 
13 
of the product showed no shift in the position in the cystine 
methylenes before and after the attempted contraction. This was 
further confirmed by the fact that the 1H NMR of a mixture of 13 and 
the isolated contraction product, a mixture which was homogeneous on 
tlc, was identical to the 1H NMR of 13. Hence, the contraction could 
not be effected. The reaction was carried out again, with a slight 
modification. Instead of stirring at room temperature for an hour, the 
reaction mixture was stirred at room temperature overnight. The 
results of this reaction were the same as before, the disulfide was 
unaffected. An attempt to contract TANDEM itself was also 
unsuccessful. 
The unsymmetrical approach~ the 
synthesis _£f !!_ 
The failure of the symmetrical approach to the synthesis of 4 
thus led to a logical alternative. An unsymmetrical lanthionine with 
four different protecting groups, as shown below, would, in principle, 
permit the cyclization of one half of the bicyclic octadepsipeptide 
followed by the other in two separate steps. 
38 
R1NH 
'( COORz 
s 
R4NH 
A COOR3 
As mentioned before, there have been few methods reported for the 
synthesis of lanthionine. The synthesis of the above lanthionine posed 
an additional challenge in that the four protecting groups, R1, Rz, R3 
and R4, had to be compatible within themselves as well as with the two 
depsipeptide ester functions and other protecting groups present in 
subsequent peptide intermediates. 
Contraction of unsymmetrical 
di sulfides 
In an attempt to synthesize an unsymmetrical lanthionine,Harpp and 
Gleason 65 subjected peptide~ to treatment with hexaethylphosphorus 
triamide. Contrary to the expected peptide ~ (see p. 39), only 
peptide ~ (see p. 40)was isolated. To explain these results, an 
equilibrium, with the intermediates as shown below, was proposed. (The 
notations used are incorrect in peptide terminology, but have been used 
for simplicity, as used by Harpp and Gleason.) 
Z-Cys-Gly-OMe 
I 
s 
I + (Et 2N)3P 
s 
I 
Z-Cys-OMe 
36 
~ 
~ 
Z-Cys-OMe 
I 
-s 
37 
Z-Cys-OMe 
I + S-P(NEt 2) 3 
39 
Z-Cys-Gly-OMe 
I + 
+ S-P(NEt 2) 3 
38 
Z-Cys-Gly-OMe 
I 
s 
40 
39 
Treatment of~ with hexaethylphosphorus triamide could result in 
the formation of two sets of charged intermediate I!_ and~, and 12._ and 
40. According to the accepted mechanism for the formation of 
lanthionine, reaction of either set should yield desired lanthionine 
41. 
Z-Cys-0Me 
I 
s-
37 
Z-Cys-0Me 
+ 
I+ 
S-P(NEt 2) 3 
39 
Z-Cys-Gly-0Me 
I+ 
S-P(NEt 2) 3 
+ 
38 
Z-Cys-Gly-0Me 
I 
s-
40 
/ 
Z-Cys-0Me 
I 
s 
I 
Z-Cys-Gly-0Me 
41 
However, reaction of I!_ with l.2_ could lead to symmetrical lanthionine 
~; analogously, reaction of 38 with 40 could lead to symmetrical 
lan thionine 43. 
Z-Cys-0Me 
I 
s 
37 
Z-Cys-Gly-0Me 
I 
s-
+ 
+ 
Z-Cys-0Me 
I + 
S-P(NEt 2) 3 
39 
Z-Cys-Gly-0Me 
I 
S-P(NEt 2) 3 
-t 
~~ 
,,& 
·,,r 
) 
Z-Cys-0Me 
I 
s 
I 
Z-Cys-0Me 
42 
Z-Cys-Gly-0Me 
I 
s 
I 
Z-Cys-Gly-0Me 
43 
Intermediates 37 and ~could also be involved in equilibria 
leading to the corresponding symmetrical disulfides 44 and 45. 
Z-Cys-OMe 
I 
s 
37 
Z-Cys-Gly-OMe 
I 
s 
40 
+ 
+ 
Z-Cys-OMe 
I + 
S-P(NEt2)3 
-40 
Z -Cy s -Gl y-OMe 
I 
S-P (NEt 2 ) 3 
38 
Z--Cys-OMe 
I 
s 
I 
s 
I 
Z--Cys-OMe 
44 
Z--Cys-Gly-OMe 
I 
s 
I 
s 
I 
Z--Cys-Gly-OMe 
45 
40 
The isolation of 45 was attributed to its extreme insolubility in 
the solvent system used. The major products of this reaction were 45 
and 42. 
The attempted contraction of another unsymmetrical disulfide~ 
also resulted in the formation of symmetrical disulfide 47 as the major 
product of reaction. 
46 47 
Symmetrical disulfide:!}_ was obtained in 88% yield. In this case, 
the formation of tris(diethylamino)phosphine sulfide was not observed. 
This observation led to the conclusion that equilibration of disulfides 
occurs faster than desulfurization. The disproportionation of 
unsymmetrical disulfides into symmetrical disulfides is known to be a 
common side reaction in the synthesis of unsymmetrical disulfides. 74 
41 
Another limitation of the above disulfide contraction method was 
that the C-terminal of the cystine had to be protected, since 
phosphines are known to react with carboxylic acids. 75 
Thus, while the formation of unsymmetrical lanthionines did not 
occur in yields of synthetic utility because of the possible equilibria 
already discussed, the contraction of symmetrical tetrapeptide ~ in 
low yields as compared to that of 26 and no contraction at all of 
hexapeptide 12_ was indicative of the fact that this reaction may be 
sensitive to steric effects. In comparison to~, the valine isopropyl 
group in tetrapeptide ~ could sterically hinder the nucleophilic 
attack of the phosphine phosphorus on the sulfur, either because of its 
size or due to a conformational effect. The same could be true for 
hexapeptide 12_, but to a larger extent, thus resulting in no 
contraction at all to yield the corresponding lanthione. This could 
also be the possible reason for the lack of reactivity of TANDEM and 
the cyclic octapeptide intermediate, towards hexaethylphosphorus 
triamide. In the latter case, the ring·conformation in the bicyclic 
structure could be such that the sulfur-sulfur bond is effectively 
shielded from nucleophilic attack by the phosphine phosphorus. Hence, 
it was necessary to look into other possible synthetic routes to the 
desired unsymmetrical lanthionine. 
Synthesis~ lanthionine by 
nucleophilic displacement of 
8-chloro-L-alanine 
Photaki and coworkers 66 reported the synthesis of unsymmetrical 
lanthionine ~ by the displacement of a halide ion with a thio anion. 
The rationale for the synthesis of 48 was two fold. One was to carry 
42 
out model studies on the cyclization leading to a cyclic pentapeptide 
equivalent to one half of the target bicyclic octapeptide ~. The 
cyclic pentapeptide 2.Q_ exists with the same number of carbon atoms in 
the ring system as in one half of the symmetrical bicyclic octapeptide 
4. As already mentioned, the proposed synthesis of pentapeptide 50 is 
shown schematically below. 
48 
0 
II 
ZNH~C-Val 
MeOOC A NHCPh3 
0 
II 
ZNH(C-Val 
+ 
H-Val 7 
Tce0-Ala+-Ser-D+-Z 
(i) TFA 
Tce0-Ala+Ser-D+Z 
49 
0 
II 
wsc 
wsc 
ZNHYC-Val 
s 
MeOOC ~ NHzTFA H0-Ala+Ser-D+Z MeOOC A NH-Ala+Ser-D<-Z 
50 
43 
Coupling of lanthionine ~ with previously synthesized 21 
tridepsipeptide using water soluble carbodiimide would yield 
pentapeptide ~- Deprotection of the lanthionine amine followed by 
reductive cleavage of the 2,2,2-trichloroethyl ester with zinc in acetic 
acid would set up 49 for a cyclization leading to cyclic pentapeptide 
so. 
The second aspect of interest in the synthesis of~ and 2.Q_ was 
the potential application of this system, with appropriate 
modifications, to the proposed synthesis of cyclic pentapeptide ~. 
shown schematically below. 
ZNHYCOOH 
~ 
TceOOC NHCPh3 
51 
0 
ll 
ZNHYC-Val 
~ TceOOC NHCPh3 
53 
H-Val 7 
tBuO-Ala+Ser-D-+Qxc 
52 
tBuO-Ala+Ser-D+-Qxc 
Lanthionine 2.!_, synthesized along the same lines as lanthionine 
~. upon coupling with tridepsipeptide 52 would lead to linear 
pentapeptide 53. The synthesis of 52 has been reported by Shin and 
44 
coworkers. 49 Deprotection of 21_, followed by cyclization, would then 
give cyclic pentapeptide 54. 
53 
tBuO-Ala+Ser-D+Qxc 
0 
II 
ZNHYC-Val 
(i) deprotection 
(ii) cyclization 
~ TceOOC NH-Ala+Ser-D-+Qxc 
54 
Treatment of 54 with zinc in acetic acid followed by coupling with 
tridepsipeptide 52 would lead to linear octapeptide 55. 
0 
II 
ZNHYC-Val 
s 
~ 
TceOOC NH-Ala+Ser-D+Qxc 
(ii) wsc, 52 
45 
0 
II 
ZNH y C-Val 
s 
Qcx-D-Ser-Ala-OtBu 
~ L------Val-C NH-Ala+Ser-~Qxc 
II 
0 
55 
Treatment of octapeptide 22_ with HBr in acetic acid 89 would 
deprotect the amine and the carboxyl functions. Cyclization would thus 
lead to bicyclic octadepsipeptide !:!_. 
The syntheses towards lanthionine ~ were carried out by the 
procedure of Photaki and coworkers 66 as per the sequence of reactions 
outlined below. 
CHzCl 
I 
HS-CHz 
I 
ZNHCHCOOH + H2NCHCOOH 
56 57 
THF/HzO, KOH 
+ -[BzlNMe 3 ] OH 
CHz-S-CHz 
I I 
ZNH-CH CH-NHz 
I I 
COOH COOH 
58 
N-Benzyloxycarbonyl-B-chloro-L-alanine ~. upon reaction with L-
cysteine 2!.._, in the presence of aqueous base under phase transfer 
conditions, gave lanthionine 58. The diacid 58 was esterified under 
standards conditions with thionyl chloride and methanol to yield 
dimethyl ester~- Treatment of~ with triphenylmethyl chloride and 
triethylamine led to the N-tritylated lanthionine 60. 
46 
CH2- s -CH 2 
SOC12 I I + Ph 3CC1, Et 3N 
58 ZNHCH CH-NH3Cl 
Me0H I I 
C00Me CO0Me 
59 
CH2 - s - CH2 
I I 
ZNHCH CHNHCPh3 I I 
CO0Me C00Me 
60 
1H NMR of £2. showed two peaks corresponding to the two methyl 
esters, at o 3.2 and o 3.7. It was inferred that the ester methyl on 
the carbon 8 to the tritylated amine group is oriented such that it 
lies in the shielding zone of phenyl rings of the trityl group, and 
hence resonates upfield. Hydrolysis of 60 under alkaline conditions 
should lead to mono acid~' since the trityl group, by virtue of its 
size, sterically shields the ester of the neighboring carboxyl from 
hydrolysis. 90 
Attempted hydrolysis of £2. with aqueous Na0H in acetone resulted 
in a complex mixture of products. The components of this mixture were 
separated by mplc. 1H NMR analysis indicated that the desired 
lanthionine mono acid 45 was not obtained. 1H NMR of one component was 
consistent for the mono acid with loss of the trityl group. The trityl 
group probably was lost upon chromatography. Thus, in our hands the 
method of Photaki and coworkers 66 was found not to be a viable route 
for the synthesis of~' particularly in view of the fact that 51 would 
47 
be the starting compound in the total synthesis, involving several 
subsequent steps, of octapeptide lanthionine !!._. 
This method was also found to be tedious in the synthesis of N-
benzyloxycarbonyl-S-c h 1 or o- L-a 1 a nine its e 1 f. An interesting 
observation was made during the synthesis of the protected amino acid. 
Commercially available S-chloro-L-alanine hydrochloride, upon treatment 
with benzyl chloroformate and NaHC03 in aqueous solution, standard 
conditions for the introduction of the benzyloxycarbonyl group, led to 
the N-benzyloxycarbonyl-S-chloro-L-alanine in yields ranging from 
20-40%. Upon increased dilution of the reaction mixture, by the 
addition of water, the N-protected amino acid was abtained in 80% 
yield. The reaction of N-benzyloxycarbonyl-13-chloro-L-alanine with L-
cysteine to yield ~. the first step in the reaction sequence leading 
to lanthionine ~. was found to be a highly sensitive one, with a 
strong dependence on the pH of the reaction mixture for the product to 
separate out of the aqueous solution as a white solid. 
The use of cesium carbonate as base to generate a thiol anion 
under mild conditions, in the alkylation of halides with the thiol 
anion, has been reported. 91 Attempts to alkylate N-benzyloxycarbony-f-
chloro-L-alanine with N-t-butyloxycarbonyl-L-cysteine methyl ester and 
cesium carbonate, in dimethylformamide solution, resulted in a complex 
mixture of products, with no desired lanthionine monoester obtained. 
Synthesis .£i. lanthionine by 
displacement of 0-activated 
serine derivatives with cysteine 
Wilchek and coworkers 68 converted the L-serine residue in peptides 
to an L-cysteine residue by tosylation of the serine hydroxyl, followed 
by nucleophilic displacement with a thio anion. 
OH 
I 
CH2 
I 
TsCl, pyridine 
OTs 
I 
CH2 I 
48 
ZNH-CH-CONHCH2COOCH2CH3 ZNH-CH-CONHCH2COOCH2CH3 
SCOCH3 I 
CH2 
I 
ZNH-CH-CONHCH2COOCH2CH3 
Ts: CH3-0so2- (p-toluenesulfonyl) 
This method was applied by the above workers 68 to various L-serine 
containing peptides using several thio anions such as those of 
triphenylthiocarbinol, benzyl mercaptan, and 2-mercaptoacetic acid. It 
was observed that when the carboxy terminal of the tosylated serine 
existed as an amide function, the displacement of the tosylate with a 
thio anion led to an optically active cysteinyl peptide. However, when 
the same reaction was carried out on a serine peptide in which the 
carboxy terminal of the tosylated serine existed as an ester, the 
resulting cysteinyl peptide was optically inactive. As already 
mentioned, this observation was attributed to the fact that in the case 
of the ester, an elimination occurs to yield an a,S-unsaturated ester. 
The mercaptide anion then adds 1,4- to the a,B-unsaturated ester to 
yield racemic cysteinyl peptide. 
Hence the adaptation of this method to the synthesis of a suitable 
optically active lanthionine or cysteinyl peptide neccesitated the 
carboxy terminal of the tosylated serine to be incorporated as an amide 
function. In order to carry out studies on the synthesis of cysteinyl 
peptides by the displacement of activated serine hydroxyl with suitable 
49 
thio anions, the following compounds 61 to 65 were outlined for 
synthesis. 
61: 
62: 
Z-L-Ser-L-Val-OMe 
I 
OR 
R = p-toluenesulfonyl 
R = imidazolyl sulfonyl 
(-so 2-{)-cH 3) 
~ (-so 2-N N) \==.I 
63: 
64: 
65: 
Z-D-Ser-OBpa 
Lval+Ser-L-Boc 
R H 
I 
OR 
R = p-toluenesulfonyl 
R = methanesulfonyl 
N-Benzyloxycarbonyl-L-serine was coupled with L-valine methyl 
ester using dicyclohexylcarbodiimide to yield dipeptide N-
benzyloxycarbonyl-L-seryl-L-valine methyl ester in 71% yield. The 
dipeptide was a crystalline compound with the 60 MHz 1H NMR spectrum 
showing the absorption peaks of the valine isopropyl methyls as a 
doublet at o 0.9. The benzyloxycarbonyl group protons resonated as 
singlets at o 5.2 and o 7.5 for the benzylic methylenes and the 
aromatics, respectively. Treatment of the dipeptide with p-toluene-
sulfonyl chloride in pyridine led to the tosylated dipeptide 61 in 60% 
yield after purification by flash chromatography. 1H NMR of 61 showed 
a quartet at o 7.8 characteristic of the aromatics of the p-
toluenesulfonyl groups overlapping with a singlet at o 7.5, the 
absorption of the benzyloxycarbonyl aromatic protons. Dipeptide 
tosylate g was then reacted with benzylmercaptan and triethylamine. 
so 
The two products of reaction were the starting dipeptide tosylate 61 
and another compound identified by 60 MHz 1H NMR spectral analysis to 
be dibenzyl disulfide. 
Wilchek and coworkers 68 reported the displacement of the tosylated 
hydroxyl group of serine in dipeptide N-benzyloxycarbonyl-L-seryl-
glycine ethyl ester with benzyl mercaptide to yield the corresponding 
cysteinyl peptide. This dipeptide tosylate was synthesized by the same 
method used in the synthesis of g. Reaction of the dipeptide tosylate 
with benzyl mercaptan and sodium methoxide in DMF solution did lead to 
the corresponding cysteine peptide. 
Z-L-Ser-Gly-OMe Z-L-Ser-Gly-OMe 
I 
OTs 
I 
S-CH2-{) 
Reaction of 61 with benzyl mercaptan under the same conditions, 
however, resulted in recovery of starting material and no desired 
cysteinyl peptide was obtained. 
Thus it was concluded that the valine isopropyl group sterically 
hinders the nucleophilic displacement by the mercaptide anion. This 
could also be a conformation effect, predominant when the amino acid 
forming the peptide bond at the C-terminal of the tosylated serine is 
valine. 
Tripeptide ~ was synthesized by coupling of dipeptide N-
benzyloxycarbonyl-0-(N-t-butyloxycarbonyl-L-valyl)-D-serine p-
bromophenacyl ester, 45 after deprotection of the valine amine terminal 
with trifluoroacetic acid, with N-t-butyloxycarbonyl-L-serine and l-
ethyl-3-(3-dimethyaminopropyl)carbodiimide hydrochloride in 98% yield. 
60 MHz 1H NMR of 63 showed the characteristic absorption signal for the 
51 
Boe-methyls at o 1.5. Treatment of 60 with 1.1 equivalents of p-
toluenesulfonyl chloride in pyridine led to a product mixture, which 
from tlc analysis indicated that mainly starting tripeptide il was 
present. Attempts to synthesize _§i with an excess of p-toluenesulfonyl 
chloride led to identical results. 
These results prompted the synthesis of tripeptide mesylate ~' 
since the methanesulfonyl group is smaller in size as compared to the 
p-toluenesulfonyl group. Reaction of tripeptide il with methane 
sulfonyl chloride in pyridine led to 65 in 96% yield. The 60 MHz 1H 
NMR of~ showed the absorption peak for the sulfonyl methyl as a sharp 
singlet at o 3.0. Attempted displacement of the mesylate ~ with 
benzylmercaptan in the presence of sodium methoxide in dimethyl 
formamide solution resulted in recovery of starting materials as 
indicated by tlc analysis. 
Hannessian and Vatele 92 reported the imidazolyl sulfonate group to 
have some unique advantages over the tosylate and mesylate in their 
studies on nucleophilic displacement of the hydroxyl groups in 
carbohydrate systems. The imidazolyl sulfonate group was found to work 
better in the case of sterically hindered hydroxyls and also to 
minimize elimination reactions. 
According to the method of Hannessian and Vatele, 92 compound g 
was synthesized by reaction of dipeptide N-benzyloxycarbonyl-L-seryl-L-
valine methyl ester with 1,1'-sulfuryl diimidazole 93 and sodium hydride 
in dimethylformamide solution. 1H NMR of 62 showed the resonance of 
the imidazole protons at o 7-8.2. Treatment of 62 with benzyl 
mercaptan and sodium methoxide in dimethylformamide resulted in 
Z-L-Ser-L-Val-OMe 
NaH 
~ 
Im: -N N 
'--==-1 
52 
Z-L-Ser-L-Val-OMe 
I 
0-S0 2-Im 
recovery of starting material with no desired cysteinyl peptide being 
formed, as indicated by tlc analysis. 
Thus, the synthesis of a suitable lanthionine or a suitable 
cysteinyl peptide by nucleophilic displacement of a tosylated serine 
with a thiol had two constraints on the tosylated serine molecule. The 
C-terminus of the tosylated serine had to exist as an amide function. 
An L-valine residue at this terminus, which would be required for the 
synthesis of target molecule!!_, was unsuitable because of its apparent 
steric hindrance to nucleophilic displacement of the tosylated serine. 
These two constraints together prompted the synthesis of the serine 
derivative 66, with a N-t-butyloxycarbonyl hydrazide function at the C-
terminal. The Boe hydrazide function can be converted to an azide 94 
and directly used for further peptide coupling. The use of azides in 
couplings of penta- and octapeptides has been reported. 95 
66 was synthesized in quantitative yield by treatment of N-
benzyloxycarbonyl-L-serine with commercially available N-t-
butyloxycarbonyl hydrazide and N,N'-dicyclohexylcarbodiimide. 1H NMR 
of 66 showed an absorption signal for the Boe-methyls as a sharp 
singlet at o 1.5. Tosylation of 66 with p-toluenesulfonyl chloride in 
pyridine led to tosylate 67. 
0 
11 
ZNH-CH-C-NHNHBoc 
I 
CH2 I 
OR 
66: R = H 
67: R = p-toluenesulfonyl 
68: R = imidazolylsulfonyl 
53 
The absorption signals for the p-toluenesulfonyl aromatics in the 1H 
NMR spectrum of !!}__ appeared as a quartet at o 7.8 overlapped by the 
absorption peak of the benzyloxycarbonyl aromatics at o 7.4. The 
serine methylenes resonated as a multiplet at o 4.4. 
Attempted displacement of tosylate !!}__ with benzyl mercaptan and 
sodium methoxide in dimethyl formamide led to a product, the 1H NMR of 
which was consistent with a cyclic intramolecular displacement product. 
0 
II 
ZNH-CH-C-NHNH-Boc 
I~ 
CH2-0Ts 
0 
II 
ZNH-CH-C-NH + TsOH 
I 
The absorption signals for the p-toluenesulfonyl aromatics were 
missing in the 1H NMR spectrum of the product. The serine methylene 
absorption was shifted upfield from o 4.4 in 67 too 3.8 in the 5-
membered cyclic product. 
The susceptibility of tosylate !!}__ to undergo intramolecular 
displacement of the tosyl group prompted the synthesis of imidazolyl 
sulfonate 68 under conditions which did not utilize the strong base 
sodium hydride. According to an alternate method reported by 
Hannessian and Vatele, 92 ~ was treated with an excess of imidazole and 
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sulfuryl chloride. The product of this reaction was identical to that 
obtained in the attempted alkylation of 66. Apparently, the 
imidazolyl sulfonate first formed, undergoes a subsequent 
intramolecular displacement to yield the cyclic product. 
Synthesis of unsymmetrical 
lanthionines 76 and 80 
using thiolsulfinates 
The synthesis of unsymmetrical disulfides containing a cysteine 
unit by the reaction of thiolsulfinates with cysteine has been 
3"1 
reported.~ Field and Khim, 96 and Block and O'Connor 97 reported 
synthetic routes to thiolsulfinates from the corresponding disulfides. 
0 
t 
R-S-S-R + HSCHz-CH-NHz 
I 
thiol 
sulfinate 
COOH 
R-S-S-CHz-CH-NHz 
I 
COOH 
+ RSOH 
Boduszek and Kice 98 reported the general reaction of a nucleophile 
with a thiolsulfinate to be as follows. 
ArS(O)SAr + Nu ) ArSO + ArSNu 
Thus, the two sulfur atoms in a disulfide or a cystine peptide 
could be distinguished towards nucleophilic attack by converting the 
disulfide to the corresponding thiol sulfinate. As already discussed, 
the first step in the method of Harpp and Gleason 65 for the synthesis 
of symmetrical lanthionines is a nucleophilic attack of the phosphine 
phosphorus on the sulfur of the disulfide. Then, thiol sulfinate, upon 
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treatment with hexaethylphosphorus triamide should yield the charged 
intermediates schematically shown below. 
[OJ 
R-S-S-R 
0 
t 
R-S-S-R 
0-
1 
R-S + S-R 
+I 
P(EtzN) 3 
The sulfenic acid formed should not interfere with the reaction of a 
thiol anion with the positively charged phosphonium intermediate. The 
thiol anion and the phosphonium intermediate should react to yield a 
lanthionine, as discussed previously. 
Thus a symmetrical and suitably protected cystine can, in principle, be 
converted to an unsymmetrical lanthionine according to the above 
scheme. 
Preliminary studies towards synthesis of a suitably protected 
lanthionine via an appropriate thiolsulfinate were carried out by the 
synthesis of thiolsulfinate i2_. N,N'-di-tert-butyloxycarbonyl-L-
cystine di-methyl ester l§_ was converted to the corresponding thiol 
sulfinate ~. according to the method of Wolfe and coworkers, 99 by 
treatment with m-chloroperbenzoic acid in methylene chloride. 
56 
BocNH C00Me BocNH C00Me 
< < s MCPBA S • 0 
I I 
s s 
~ A 
Boe-NH C00Me BocNH C00Me 
26 69 
~ was reacted with one equivalent of hexaethylphosphorus triamide 
and N-t-butyloxycarbonyl-1-cysteine t-butyl ester (J!l.) in benzene 
solution. The reaction mixture was chromatographed on the mplc and the 
fractions separated and analyzed by tlc and 60 MHz 1H NMR. The major 
product of the reaction was disulfide 71 isolated in 50% yield. 1H NMR 
of 71 showed the absorption peaks for the cystine methylenes as a 
doublet at o 3.2, thus confirming the disulfide. Small amounts of 
symmetrical disulfides 26 and 72 were identified by tlc and 1H NMR. 
BocNH C00Me ( 
(Et 2N)3P s 69 I 
BocNH-CH-CH2-SH s I /( C00tBu 
BocNH C00tBu 
70 
71 
BocNH y C00Me 
s 
I 
s 
BocNHA C0OMe 
26 
BocNH y C00tBu 
s 
I 
s 
BocNH A C00tBu 
72 
57 
Cysteine 2.Q_ was synthesized by reductive cleavage of cystine lJ:.. 
with zinc and 5% acetic acid in ether in near quantitative yields. 72 
itself was synthesized by treatment of L-cystine di-t-butyl ester 
dihydrochloridelOO with di-t-butyl dicarbonate and triethylamine in 
dimethylformamide solution. 
HCl 0 NH2 y C00tBu 
s 
I 
s 
HCl "NH2 A C00tBu 
DTDC 
BocNH y C00tBu 
s 
I 
s 
BocNH A C00tBu 
72 
DTDC: Di-t-butyl dicarbonate 
70 
Ether 
The chemistry, reactions and synthetic applications of thiol-
sulfinates have been well documented.lOl-l0 3 To the best of our 
knowledge, this is the first example of the use of a thiolsulfinate in 
the synthesis of a cystine or cystine containing peptide. 
The synthesis of unsymmetrical cystine !.2 was carried out with the 
same sequence of reactions, starting with a different thiosulfinate I!!_. 
58 
N,N'-Di-benzyloxycarbonyl-L-cystine diethyl ester (Z1)was converted to 
the corresponding thiolsulfinate by treatment with m-chloroperbenzoic 
acid. This was then reacted with hexaethylphosphorus triamide and N-t-
butyloxycarbonyl-L-cysteine t-butyl ester, to give unsymmetrical 
cystine 75 in 43% yield. 
ZNH COOEt 
ZNH 
< s 
I 
s 
,,,<._ COOEt 
73 
BocNH"-./' 
/ SH 
tBuOOC 
70 
MCPBA 
ZNH 
BocNH 
ZNH COOEt 
< S ~ 0 
I 
> ZNH COOEt 
< s 
I 
s 
74 
COOEt 
A COOtBu 
75 
90 MHz 1H NMR of 75 showed the absorption peaks for the four 
cystine methylenes as a triplet at o 3.2 ppm. Apparently, this triplet 
results from two overlapping doublets, the two pairs of cystine 
methylenes being nonequivalent in the unsymmetrical cystine. The same 
reaction, when carried out under N2 , resulted in the formation of 75 in 
55% yield. The N2 atmosphere would minimize formation of cystine !.l:... by
the oxidation of cysteine 70. 
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Treatment of unsymmetrical cystine 21 with hexaethylphosphorus 
triamide resulted in the formation of lanthionine ]!}_ as the major 
product, in 52% isolated yield, with small amounts of symmetrical 
disulfides 72 and 73 as identified by tlc analysis and by NMR analysis. 
BocNH 
ZNH 
< COOtBu 
s 
I 
~ 
COOEt 
75 
BocNH < COOtBu 
ZNH ~COOEt 
76 
+ 
ZNH~ 
s 
I 
COOEt 
s 
ZNHACOOEt 
73 
+ 72 
1H NMR of ]!}_ showed the lanthionine methylenes resonating as a 
triplet centered at o 3.0 ppm, as against o 3.2 ppm in the case of 
cystine 21• Combustion analysis data were in agreement with calculated 
values, thus confirming the disulfide contraction. Hence, it was 
established that the contraction can, indeed, be effected on an 
unsymmetrical cystine. 
Attempts to convert thiolsulfinates 74 directly to J.!:.. by the use 
of an excess of hexaethylphosphorus triamide resulted in the formation 
of 21 in 15-22% yields. A possible explanation for these observations 
could be an equilibrium shown below. 
ZNH< COOEt 
S ~ 0 
I 
s 
ZNH COOEt 
74 
ZNHYCOOEt 
s- 0-
+ 
ZNH Y+COOEt 
S-P(Et 2N) 3 
60 
ZNH 
+ ~ BocNH C00tBu + s ~ 
Bo'cNH C00tBu 
Thus an excess of hexaethylphosphorus triamide would shift the 
equilibrium to the left, which could then lead to other side reaction 
products. 
Lanthionine 76 is completely unsymmetrical with four different 
protecting groups on the two amino and two carboxy terminals. These 
groups are compatible with each other and can be selectively removed in 
the proper sequence necessary in the proposed synthesis of!!._. The 
ethyl ester can be hydrolyzed with aqueous base without hydrolysis of 
the t-butyl ester. The Boe group and the t-butyl ester are both 
susceptible to acidolytic cleavage. However, conditions for the 
selective removal of the Boe group in the presence of t-butyl ester 
have been reported. 104 The removal of both the Boe and t-butyl ester 
functions will not affect the depsipeptide ester bonds present, 
subsequently. The benzyloxycarbonyl group can be removed in the last 
step of the reaction sequence, before cyclization. Thus, in Ji!.., the 
synthesis of an unsymmetrical lanthionine suitable for our proposed 
synthesis of bicyclic octapeptide lanthionine !!._ has been accomplished. 
The method of synthesis of unsymmetrical lanthionine 76 via the 
corresponding thiolsulfinate was applied to the synthesis of another 
unsymmetrical lanthionine ~- Lanthionine 80 has the 2,2,2-
trichloroethyloxycarbonyl (Toc) 10 5 group on the amine nitrogen in lieu 
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of the Boe group present in J.j_. The advantage of this protecting group 
is that it can be removed by reductive cleavage with zinc in acetic 
acid. This aspect of removal of the Toe group facilitates the 
TocNH 
ZNH 
y COOtBu 
s 
ACOOEt 
80 
synthesis of octapeptide lanthionine ~, in that the trichloroethyl 
es ter function is also cleaved under the same conditions, and hence 
both the amine and carboxyl group can be deprotected in one step. A 
schematic route proposed for the synthesis of lanthionine ~ is shown 
below. 
TocNH y COOtBu TocNH y COOtBu hydrolysis 
s s ;z aq base 
ZNH / COOR ZNH COOEt 
80 
Toe: 2,2,2-trichloroethyloxycarbonyl 
coupling with 
Qxc-D-Ser-Ala-OTce 
Lval-H 
TocNH YS COOtBu 
Qxc-D-Ser-Ala-OTce 
Lval-C/NHZ 
II 
0 
81 
62 
Qxc-D-Ser-Ala-OH NH2 '( COOtBu 
Qxc-D-Ser-Ala-NHY C00tBu 
s 
/( 
Val-C NHZ 
II 
0 
83 
wsc 
> ~ 
Val--C NHZ 
II 
0 
82 
Qxc-D-Ser-Ala-NH COOR 
deesterification Y 
0 
II 
s 
/ 
Val-C NHZ 
II 
0 
84 
coupling with 
Qxc-D-Ser-Ala-NH y C-Val 
H-Val7 
TceOAla +Ser-D+Qxc 
s 
/ 
Val-C NHZ TceO-Ala+Ser-D+Qxc 
II 
0 
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(i) deprotection 
(ii) cyclization 
Qxc-D-Ser-Ala-NH 
Val-C 
II 
0 
0 
ll 
'?: C-Val 
~ 
NH-Ala+Ser-D-Qxc 
4 
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N,N'-Di-2,2,2-trichloroethoxycarbonyl-L-cys tine t-but yl ester !.}_ 
was synthesized by treatment of L-cystine di-t-butyl ester 
dihydrochloride with 2,2,2-trichloroethyloxycarbonyl chloride and 
NaHC03 in aqueous solution in 84% yield after purification on the mplc. 
90 MHz 1H NMR of !.}_ showed the absorption peak for the 2,2,2-
trichloroethyloxycarbonyl methylenes as a sharp singlet at o 4.8 ppm. 
Elemental analysis data were in satisfactory agreement with the 
theoretical values. 77 was treated with m-chloroperbenzoic acid in 
CH2c1 2 resulting in the corresponding thiolsulfinate 78. The 
thiolsulfinate 78 was treated, without further purification, with one 
equivalent of hexaethylphosphorus triamide and N-benzyloxycarbonyl-L-
cysteine ethyl ester in benzene solution under an atmosphere of 
nitrogen. The reaction mixture was purified on the mplc and 
unsymmetrical disulfide 22_ was isolated in 55% yield. 1H NMR of 79 
showed the absorption of the cystine methylenes as a doublet at o 3.2 
ppm. The 2,2,2-trichloroethyloxycarbonyl methylenes resonated as a 
singlet at o 4.8 ppm. Combustion analysis data were in satisfactory 
agreement with calculated values. 
HCl "NH2 y C00tBu 
s 
I 
s 
HCl 0 NH2 A C00tBu 
MCPBA 
TocNH y C00tBu 
s-o 
I 
s 
~ TocNH COOtBu 
78 
79 
Toe-Cl 
ZNH\/' 
/ SH 
EtOOC 
TocNHY 
s 
I 
s 
COOtBu 
A TocNH COOtBu 
77 
TocNH y C00tBu 
s 
I 
s 
A 
ZNH COOEt 
79 
TocNH y CO0tBu 
s 
ZNHACOOEt 
80 
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N-Benzyloxycarbonyl-L-cysteine ethyl ester was synthesized by 
reductive cleavage of the corresponding cystine with zinc in acetic 
acid. 
ZNH< 
s 
I 
s 
A 
COOEt 
ZNH COOEt 
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COOEt 
79 was treated with 1.1 equivalents of hexaethylphosphorus 
triamide in benzene solution. The reaction product was purified on the 
mplc and the fraction having the same Rf value as for 79 was isolated. 
90 MHz 1H NMR of this fraction indicated it to be a mixture of 
lanthionine 80 and cystine JJ_. The cystine methylenes of ]J_ resonated 
as a doublet at o 3.2 ppm while the lanthionine methylenes in 80 
appeared as a doublet at o 3.0 ppm. From the intensities of the peaks, 
80 was found to be the major product. Treatment of 79 with 2.5 
equivalents of hexaethylphosphorus triamide resulted in the formation 
of lanthionine ~ in 58% yield. In comparison, the lanthionine 
contraction of cystine !.J.... to lanthionine 76 was effected by 1.1 
equivalents of hexaethylphosphorus triamide. Lanthionine 76 has the 
t-butyloxycarbonyl group on one of the two amine nitrogens while~ has 
the 2,2,2-trichloroethyloxycarbonyl group, with the rest of the 
protecting groups in!...!!__ and~ being indentical. Thus, the 2,2,2-
trichloroethyloxycarbonyl group influences the lanthionine contraction. 
The role of the protecting group in this reaction, however, is not 
understood. 
The synthesis of lanthionine 80 was carried out with a different 
thiolsulfinate ].!!.. using the same sequence of reactions as for the above 
synthesis of 80, as outlined below. 
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ZNH < COOEt ZNH y C00Et 
S- • 0 (EtzN) 3P s 
I I 
s TocNHY s / SH A tBu00C 
ZNH C00Et TocNH C00tBu 
86 
74 79 
ZNH C00Et y 
Benzene 
TocNH ~COOtBu 
80 
The synthesis of N-trichloroethyloxycarbonyl-1-cysteine t-butyl 
ester ~ by reductive cleavage with zinc and acetic acid had a 
potential problem in that the N-protecting group itself was susceptible 
to removal under these conditions. However, the reduction of the 
disulfide bond is effected under milder conditions using 5% acetic 
acid, whereas the removal of the protecting group needs 90% acetic 
acid. Attempts to synthesize~ by the reductive cleavage of cystine 
77 with zinc in 5% acetic acid were unsuccesful. The method of 
Erickson and Khan, 106 using tri-n-butylphosphine in aqueous methanol, 
resulted in the conversion of!}_ to~ in near quantitative yields. 
The product of this reaction could be used directly without further 
purification. This method of synthesis of 80 had two advantages over 
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the first on e . Unsymmetrical cystine !J.... was obtained in 65% yield as 
compared to 55% by the previous method. The synthesis of N,N'-di-
2,2,2-trichloroethyloxycarbonyl-L-cystine di-t-butyl ester!.}_, which is 
the precursor of thiol sulfinate !..!_ and cysteine ~, is tedious as 
compared to that of N,N'-di-benzyloxycarbonyl-L-cystine diethyl ester, 
precursor to thiol sulfinate J...!!....• In the reaction of thiolsulfinate 
with cysteine, only one half of the cystine molecule corresponding to 
the thiolsulfinate is incorporated into the unsymmetrical cystine. 
Thus, the use of the more easily obtained thiolsulfinate 74 was found 
to be facile in the synthesis of 80. 
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CONCLUSION 
The attempted synthesis of bicyclic octadepsipeptide lanthionine i 
by the symmetrical approach was carried out. Symmetrical lanthionine 
N,N'-di-t-butyloxycarbonyl-1-lanthionine dimethyl ester (27) was 
prepared by a contraction of the corresponding cystine ~ using 
alkylaminophosphine, according to the method of Harpp and Gleason. 65 
This method could not be applied to the lanthionine contraction of 
hexapeptide 12_, cyclic octapeptide g and TANDEM. Apparently the 
reaction is sensitive to steric and conformational effects. Starting 
with]:}_, linear octapeptides ~ and l_l were prepared. Attempts to 
cyclize 29 and 32 to the bicyclic octapeptide, however, were 
unsuccessful. 
The failure of the cyclizations of~ and l_l led to the logical 
alternative, a suitably protected unsymmetrical lanthionine with four 
different protecting groups. These protecting groups have to be 
compatible within themselves as well as with the depsipeptide ester 
bonds present subsequently in the peptide intermediates. 
Attempts to synthesize an unsymmetrical lanthionine by the 
nucleophilic displacement of the chloride ion from N-benzyloxycarbonyl-
S-chloro-L-alanine with the thiol function of cysteine under phase 
transfer conditions, were unsuccessful. The displacement of the 
sulfonate-activated serine hydroxyl in L-serine containing peptides 
with mercaptide anion was studied. The displacement could not be 
effected when the C-terminus of the tosylated serine was incorporated 
as an amide bond with valine, starting tosylate being recovered in the 
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reaction. Valine as the C-terminal amino acid of the tosylated serine, 
appears to sterically hinder the nucleophilic displacement by 
mercaptide anion. 
Unsymmetrical cystines were synthesized by the reaction of 
thiosulfinate with cysteine. To the best of our knowledge, this is the 
first example of the use of thiol sulfinates for the synthesis of a 
cystine or cystine peptide. 
0 
f R'-SH 
R-S-S-R R-S-S-R I + RSOH 
Suitably protected cystines were converted to the corresponding 
thiol sulfinates by peracid oxidation. Upon reaction with N- and C-
protected cysteines, these led to the respective unsymmetrical cystines 
75 and 76. Lanthionine contraction of these unsymmetrical cystines was 
effected with hexaethylphosphorus triamide in benzene solution. This 
is contrary to the observation of Harpp and Gleason, 65 who found this 
method unsuitable for the synthesis of unsymmetrical lanthionines. 
The synthesis of two unsymmetrical lanthionines 76 and 80 with the 
appropriate protecting groups necessary for our proposed synthesis of 
octapeptide lanthionine 4 was accomplished. Further studies towards~, 
however, were not pursued. 
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EXPERIMENTAL 
Meltings points were determined with a Thomas-Hoover melting point 
apparatus, and are uncorrected. 1H NMR spectra were recorded on a 
Varian EM-360, XL-100-12, JEOL FX-90 or a Nicolet NT-360 spectrometer; 
satisfactory NMR data were obtained for all compounds and data for 
selected intermediates are reported. The format of the data report is: 
chemical shift (in ,5 units), multiplicity (s = singlet, d = doublet, 
t = triplet, m = multiplet), integral intensity, and source. Solvents 
were removed in vacuo on a Buchler rotary evaporator. Thin layer 
chromatography was performed on commercially available silica-gel 
plates; [Whatman MK6F-l x 3", silica gel 40 °A], with flourescent 
indicator; components were located under ultraviolet irradiation and 
with iodine vapors. The solvent systems used were: A) hexane-acetone, 
8:2; B) hexane-acetone, 7:3; and C) hexane-acetone, 6:4. Medium 
pressure liquid chromatography (mplc) was performed on columns packed 
with silica gel 60 (0.040-0.064 mm). 
The amino acids, their derivatives, coupling reagents and other 
chemicals used were obtained from commercial sources. The THF used was 
distilled from sodium benzophenone ketyl. DMF was distilled over CaH2 
and stored over appropriate molecular sieves. CH2c1 2 was distilled 
over P 2o5• All other solvents used were distilled in glass prior to 
use. 
Elemental analyses were performed by M-H-W Laboratories, Phoenix, 
Arizona. 
Synthesis of N,N'-di-tert-butyloxy-
carbonyl-L=cystine dimethyl ester (26) 
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To a stirred suspension of L-cystine dimethyl ester 
dihydrochloride (8.52 g, 25 mmol) in 125 ml of DMF, triethylamine (7.01 
ml, 50 mmol) was added with stirring, followed by di-t-butyl 
dicarbonate (10.9 g, 50 mmol). After stirring at room temperature for 
5 hr, the solvent was removed in vacuo and the residue was taken up in 
10% citric acid. The aqueous phase was extracted four times with ethyl 
acetate; the combined organic phase was washed with sat NaHC03, brine 
and dried over Na2so4• Upon removal of solvent in vacuo a white solid 
was obtained. This solid was crystallized from absolute ethanol-pet. 
ether to give 9,5 g (80%) of ~; m.p. 98-100°; reported m.p. 96-97°;1° 7 
tlc (solvent A) Rf (0.23); 1H NMR (60 MHz, CDC13) o 1.5 (s, 18 H, Boe 
Me's), 3.2 (d, 4 H, cystine methylenes), 3.9 (s, 6H, methyl ester) 4.6 
( m , 2 H , a - H' s ) , 5 • 8 ( d , 2 H , NH) • 
Synthesis~ N,N'-di-tert-butyloxy-
carbonyl-L-lanthionine dimethyl 
ester (27) 
To a solution of 2 (8.53 g, 25 mmol) in benzene (80 ml) was added 
hexaethylphosphorus triamide (6.18 g, 25 mmol) dropwise, with stirring. 
The reaction mixture was stirred at room temperature for 1 hr. The 
solvent was removed in vacuo and the resulting oil purified on the 
medium pressure liquid chromatograph using a 25 mm diameter column; 
with 20% acetone in hexane as the eluting solvent system. Pure 
lanthionine ]J_ 6.32 g (81%) was obtained as an oil, which solidified 
upon standing for several days; m.p. 69-72°; tlc (solvent A) Rf (0.23); 
1H NMR (60 MHz, CDC13 o 1.5 (s, 18 H, Boe Me's), 3.0 (d, 4 H, 
lanthionine methylenes), 3.9 (s, 6H, methyl ester), 4.6 (m, 2H, a-H's), 
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5.8 (d, 2 H, NH). (Found: C, 49.17; H, 7.54; S, 7.8. c 18 H32 N208S 
requires: C, 49.54; H, 7.34; S, 7.34 %). 
Synthesis~ hexapeptide 
lanthionine 28 
A. Synthesis~ N-benzyloxycarbonyl-0-(N-t-butyloxycarbonyl-L-
valyl)-d-serine p-bromophenacyl ester. To N-benzyloxycarbonyl-D-serine 
p-bromophenacyl ester 108 (4.36 g, 10 mmol) in 60 ml pyridine was added 
N-t-butyloxycarbonyl-L-valine (3.24 g, 15 mmol), and the solution was 
cooled to 0° in an ice-salt bath. N,N'-dicylohexylcarbodiimide (3.15 
g, 15 mmol) was added, and the reaction mixture was stirred at 0° for 
3-4 hr followed by stirring at room temp. overnight. The mixture was 
filtered, and the filtrate was concentrated on the vacuum evaporator to 
yield an oil. This oil was dissolved in ethyl acetate and washed with 
H2o (50 ml), sat NaHC0 3 aq (2 x 25 ml), 10% citric acid (2 x 25 ml), 
and H2o (50 ml). The organic phase was dried over Na 2 so4 and 
concentrated to yield an oil. The oil was purified on the mplc with 
20% acetone in hexane as elutant, to yield 5.4 g (85%) of a white 
solid; m.p. 95-96°; reported m.p. 97-98°. 45 This compound was 
identical to an authentic sample. 
B. Synthesis ~ ~- To a stirred solution of ]:]_ (l.5 g, 3.4 
mmol) in 80% aqueous dioxane was added to 2N NaOH dropwise to pH 10. 
The solution was maintained at pH 10 by subsequent addition of 2 N NaOH 
with stirring at room temp for 1/2 hr. The reaction mixture was washed 
with CH2c1 2 (20 ml) to remove unreacted diester, acidified in cold to 
pH 2 with 1 N HCl, and extracted with ethyl acetate (3 x 25 ml). The 
combined organic phase was washed with water, brine and dried over 
Na 2so4• Removal of solvent in vacuo yielded 1.17 g (86%) of diacid. 
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To the dipeptide synthesized in Step A (2.0 g, 3.15 mmol), was 
added 10 ml anhyd trifluoroacetic acid and the reaction mixture was 
stirred at room temp. for 1 hr. The solvent was removed in vacuo and 
the residue partitioned between sat NaHC03 aq and ethyl acetate. After 
separation, the organic phase was washed with sat NaHC0 3 aq (2 x 25 
ml), H2o (2 x 25 ml), and brine (50 ml). The solvent was dried over 
Na 2so4 and evaporated to yield an oil. To this oil, dissolved in THF 
(10 ml), was added a solution of the above diacid (0.61 g, 1 mmol) in 
THF (10 ml), and the mixture was cooled to 0° in an ice-salt bath. 
After addition of 1-hydroxybenzotriazole hydrate (0.93 g, 6.85 mmol) 
and l-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.61 g, 
3.2 mmol), the mixture was stirred at o0 for 1.5 hr, followed by 
stirring at room temp. overnight. 
The solvent was removed in vacuo, and the residual oil was 
dissolved in CHC13 (50 ml). The organic phase was washed with water 
(50 ml), 1 N HCl (2 x 50 ml), sat NaHC0 3 aq (75 ml), water (25 ml) and 
brine in succession and dried over Na2so4• The solvent was removed in 
vacuo to yield a foam. Purification on the mplc with 30% acetone in 
hexane as eluting solvent led to 1.29 g (60%) of~; tlc (solvent B) 
Rf: 0.2; 1H NMR (360 MHz, CDC13 ) o 0.9 (d, 12 H, Val Me's), 1.4 (s, 18 
H, Boe Me's), 2.2 (m, 2 H, Val a-H's), 2.9 (d, 4 H, lanthionine 
methylenes), 4-6.5 (24 H, Ser methylenes, Ser and lanthionine a-H's, 
benzyloxycarbonyl and phenacyl methylenes, NH' s), 7 .4 (d, 10 H, 
benzyloxycarbonyl aromatic), 7.7 (A 2B2 q, 8 H, phenacyl aromatic). 
( Found : C , 5 3. 3 0 ; H , 5 • 5 8 ; N , 5. 5 0 ; S , 2. 31. C 6 4 H 7 8 0 jN 6 Br z S re q u i re s : 
C, 53.26; H, 5.41; N, 5.80; S, 2.20 %). 
Synthesis~ octapeptide 
lanthionine 29 
74 
To~ (1.15 g, 0.8 mml) was added trifluoroacetic acid (5 ml) and 
the mixture stirred at room temp. for 1 hr. After removal of solvent 
in vacuo, diethyl ether (5 ml) was added and the mixture concentrated 
to dryness, twice. To the residue, dissolved in 10 ml of THF, was 
added N-t-butyloxycarbonyl-L-alanine (0.32 g, 1.7 mmol), N-
methylmorpholine (0.19 ml) and the reaction mixture cooled to o0 c in an 
ice-salt bath. 1-Hydroxybenzotriazole hydrate (0.22 g, 1.6 mmol) was 
added, followed by l-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride and the reaction mixture stirred at o0 for 3 hr followed 
by stirring overnight at room temperature. 
The solvent was removed in vacuo and the residue dissolved in 
ethyl acetate (25 ml). The ethyl acetate extract was washed with water 
(25 ml), sat NaHC0 3 aq (15 ml), 1 N HCl (25 ml), sat NaHC0 3 (15 ml) and 
brine in succession. The ethyl acetate phase was dried over Na2S04 and 
concentrated to an oil. The oil was purified on the mplc with 40% 
acetone in hexane as the elutant to yield 0.71 g (55%) of~; tlc 
(solvent C) Rf 0.21; 1H NMR (360 MHz, CDC13 ) 8 0.9 (d, 12 H, Val 
Me's), 1.3 (bs, 6 H, Ala Me's), 1.5 (s, 18 H, Boe Me's), 2.2 (m, 2 H, 
Val a-H's), 2.9 (bd, 4 H, lanthionine methylenes) 4-6.5 (24 H, Ser 
me thylenes, Ser and Ala a -H's, benzyloxycarbonyl and phenacyl 
methylenes, NH), 7.4 (s, 10 H, benzyloxycarbonyl aromatic), 7.7 (A 2B2 
q, 8H, phenacylaromatic). (Found: C, 52.72; H, 5.50; N, 7.03. 
• 
75 
Attempted synthesis~ octadepsipeptide 
31 from 29 
A stirred solution of 22_ (0.61 g, 0.4 mmol) in 90% aqueous acetic 
acid (10 ml) was cooled to 0° in an ice-salt bath. Zinc powder (1.25 
g, 19.2 mmol) was added slowly, in portions, over a period of 15 min 
and the reaction mixture stirred at o0 for 1.5 hr. The reaction 
mixture was filtered and the ppt washed well with 90% acetic acid. The 
filtrate and washings were combined and concentrated to dryness. The 
residue was partitioned between 1 N HCl (SO ml) and ethyl acetate-
methanol (4:1 v/v, 50 ml). The organic phase was separated and the 
a queous phase saturated with NaCl. The saturated aqueous phase was 
extracted with ethyl acetate. The combined organic phase was washed 
with water twice, dried over Na2so4 , and concentrated to an oil. 
To the above oil was added trifluoroacetic acid (5 ml) and the 
mixture was stirred at room temp for 1 hr. The mixture was evaporated 
t o dryness in vacuo, diethyl ether (2 x 5 ml) was added and 
c on c entr a ted to dryness. The residue was dissolved in anhyd N,N-
dimethylformamide (30 ml) and cooled to o0 in an ice-salt bath. N-
Methylmorpholine (0.09 ml, 0.8 mmol) was added followed by N-hydroxy-
succinimide (0.19 g), and the reaction mixture diluted with THF (500 
m 1). After cooling to 0°, l-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride was added and the mixture stirred at 0° for 
3 hr and at room temp. for 5 days. 
The reaction mixture was concentrated in vacuo and residue 
dissolved in ethyl acetate (75 ml). The ethyl acetate extract was then 
filtered to remove solid and washed ppt washed well with ethyl acetate. 
The combined organic phase was washed with 1 N HCl (25 ml), sat NaHC03 
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aq (25 ml) and water (SO ml) in succession, dried over Na 2 so4 and 
concentrated to an oil. 
Tlc analysis (solvents Band C) showed the product to be a complex 
mixture, with no trace of desired cyclic octapeptide 31. An authentic 
sample with a disulfide linkage, a known intermediate in the synthesis 
of TANDEM, was used for comparison. 
Repeating the above procedure with CH2 c1 2 in lieu of THF as 
solvent gave similar results. 
Synthesis~ octapeptide E 
To N-benzyloxycarbonyl-0-(t-butyloxycarbonyl-L-valyl)-D-seryl-L-
alanine 2,2,2-trichloroethyl ester 21 (3.84 g, 6 mmol) was added 
trifluoroacetic acid (10 ml), CH2c1 2 (10 ml) and the mixture was 
stirred at room temp. for 1 hr. The solvent was removed in vacuo, 
anhyd ether (2 x 10 ml) added, and evaporated to dryness. To the 
residue was added anhyd ether again (SO ml) and the flask scratched 
with a spatula. Upon cooling in the refrigerator for 2 hours, a white 
crystalline ppt was obtained. The solid was separated by filtration, 
washed well with anhyd ether and dried in the dessicator overnight. 
To the dried trifluoroacetate salt was added CH2c1 2 (10 ml) and N-
methylmorpholine (1.2 ml), when the solution went clear. To this clear 
solution was added a solution of N,N'-di-tertbutyloxycarbonyl-L-
lanthionine (diacid obtained upon hydrolysis of !I) (1.23 g, 3 mmol) in 
CH2 c1 2 (65 ml). The mixture was cooled to o0 in an ice-salt bath. 
After addition of l-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (1.2 g, 6.3 mmol) and 1-hydroxybenzotriazole monohydrate 
(0.14 g, 0.9 mmol), the reaction mixture was stirred at 0° for 4 hr 
followed by stirring at room temp. overnight. 
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Solvent was removed in vacuo and the residue dissolved in ethyl 
acetate (7 5 ml). The organic phase was washed with H20 (50 ml), sat 
NaHC03 aq (50 ml), 10% citric acid (50 ml), sat NaHC0 3 aq (50 ml) and 
H2o (2 x 25 ml) in succession, and dried over Na2so4• Upon evaporation 
of solvent, an oil was obtained. The oil was purified on the mplc with 
30% acetone in hexane as the elutant, to yield 2.5 g (57.3%) of E as 
an oil; tlc (solvent B) Rf: 0.22; 1H NMR (360 MHz, CDC13 ) o 0.9 (d, 12 
H, Val Me's), 1.3-1.5 (overlapping s, 24 H, Boe, Ala Me's), 2.2 (m, 2 
H, Val a-H's), 2.9 (bd, 4 H, lanthionine methylenes) 4-6.5 (24 H, Ser 
mehtylenes, Ser and Ala a-H's, benzyloxycarbonyl and trichloroethyl 
me thylenes, NH), 7.2 (s, 10 H, benzyloxycarbonyl aromatics). (Found: 
C, 48.0; H, 5.69; N, 7.57. c58 H80 c1 6N8 0 20 s requires: 
5.51; N, 7.71 %). 
Attempted synthesis of cyclic 
oc ta peptide l!_ from E 
C, 47.9; H, 
To a stirred cold solution of E (2.18 g, 1.5 mmol) in 90% aqueous 
a cetic acid (35 ml), was added zinc powder (4.7 g, 72 mmol) slowly, in 
portions, over a period of 20 min with stirring. The mixture was 
s ubsequently stirred at 0° for 1.5 hr. The reaction mixture was 
f iltered and the ppt washed well with 90% aqueous acetic acid. The 
filtrate and washings were combined and concentrated in vacuo to 
dryness. The residue was partitioned between 1 N HCl (75 ml) and ethyl 
acetate-methanol (4:1 v/v, 100 ml). The organic phase was separated 
and the aqueous phase saturated with NaCl. The saturated aqueous phase 
was extracted with ethyl acetate (2 x 50 ml). The combined ethyl 
acetate extract was washed several times with H2o, and dried over 
Na 2S04• Evaporation of solvent gave 1.6 g of an oil. 
l 
o) 
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To this oil was added trifluoroacetic acid (10 ml) and the 
solution stirred at room temp. for 1 hr, then concentrated to a sticky 
residue. To the residue was added ether (10 ml), triturated well and 
evaporated to complete dryness using a high vacuum rotavapor. 
The residue was dissolved in 10 ml anhyd dimethylformamide and 
cooled to 0° in an ice-salt bath. N-Hydroxysuccinimide and N-
methylmorpholine were added, and the reaction mixture diluted with 500 
ml THF. After cooling to o0 , l-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride was added and the mixture stirred at 0° for 
3 hr and at room temp. for 5 days. 
The reaction mixture was concentrated in vacuo and the residue 
dissolved in ethyl acetate (100 ml). Insoluble material was removed by 
filtration and the ppt washed well with ethyl acetate. The combined 
washings and filtrate were washed with 1 N HCl (2 x 50 ml), sat NaHC03 
aq (50 ml) and H2o (50 ml). 
TLC analysis of product (solvents Band C) showed the product to 
be a complex mixture, with no desired octapeptide 31. 
Synthesis~ tetrapeptide ~ 
N,N'-Di-t-butyloxycarbonyl-L-cystine (0.88 g, 2 mmol) and L-valine 
methyl ester (0.52 g, 4 mmol) were dissolved in pyridine (10 ml) and 
the solution cooled to o0 in ice-salt bath. N,N'-
dicyclohexylcarbodiimide (0.88 g, 4.2 mmol) was added and the reaction 
mixture stirred at o0 for 3 hr and room temperature overnight. 
The reaction mixture was filtered and ppt washed with pyridine. 
The combined filtrate and washings were evaporated in vacuo and the 
residue dissolved in ethyl acetate (25 ml). The organic phase was 
washed with sat NaHC03 aq (2 x 25 ml) and dried over MgS04. Solvent 
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was removed in vacuo to yield a white solid which crystallized from 
hexane-acetone to give lg (75%) of~; m.p. 81-82°; tlc (solvent-C) Rf 
0.42; 1H NMR (60 MHz, CDC13 ) 8 1.0 (d, 12 H, Val Me's), 1.5 (s, 18 H, 
Boe Me's), 3.2 (d, 4 H, cystine methylenes), 3.8 (s, 6 H, methyl 
ester), 4.7 (m, 2 H, a-H's). 
Lanthionine contraction of 
tetrapeptide ~ 
To tetrapeptide ~ (1.33g, 2 mmol) in benzene (10 ml) was added 
hexaethylphosphorus triamide (0.6 g, 2.4 mmol) dropwise, with stirring, 
and the mixture was stirred at room temp. for 2 hr. Solvent was 
removed in vacuo to yield an oil. The oil was purified on the mplc 
with 20% acetone in hexane as the eluting solvent to give 0.4 g (31%) 
of lanthionine as an amorphous solid; tlc (solvent C) Rf 0.42; 1H NMR 
(60 MHz, CDC13 ) 8 1.0 (d, 12 H, Val Me's), 1.5 (s, 18 H, Boe Me's), 3.0 
(d, 4 H, lanthionine methylenes), 3.8 (s, 6H, methyl ester), 4.7 (m, 2 
H, a-H's). (Found: C, 53.18; H, 8.02; N, 9.28. 
requires: C, 52.99; H, 7.89; N, 8.83%). 
Synthesis of hexapeptide ll 
To N-benzyloxycarbonyl-0-(N-t-butyloxycarbonyl-L-valyl)-D-serine 
p-bromophenacyl ester 45 (2.0 g, 3.2 mmol) was added trifluoroacetic 
acid (10 ml) and the mixture was stirred at room temp. for 1 hr. The 
mixture was concentrated on the rotavapor, and the residue dissolved in 
diethyl ether (100 ml). The organic phase was washed with sat NaHC03 
aq (2 x SO ml) and H20 (SO ml), and dried over MgS04• Removal of the 
solvent led to an oil. To a stirred solution of this oil in THF (20 
ml) was added N,N'-di-t-butyloxycarbonyl-L-cystine (0.66 g, 1.5 mmol) 
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and 1-hydroxybenzotriazole monohydrate (0.93 g, 6.9 mmol). The mixture 
cooled to o0 in ice-salt bath. To the chilled solution, l-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride was added, and the 
reaction mixture stirred at o0 for 2 hr, followed by stirring at room 
temp. overnight. 
Solvent was removed in vacuo and the resulting oil dissolved in 
CHC13 (100 ml). The organic phase was washed with H2o (50 ml), 2 N HCl 
(2 x 50 ml), sat NaHco 3 aq (2 x 50 ml), H2o (50 ml) and brine (25 ml) 
in succession and dried over MgS0 4 • Removal of the solvent led to a 
foam which was purified on mplc with 30% acetone in hexane as the 
eluting solvent system, to yield 1.1 g (50%) of~; tlc (solvent B) Rf: 
0.2; 1H NMR (60 MHz, CDC13 ) o 0.9 (d, 12 H, Val Me's), 1.4 (s, 18 H, 
Boe Me's), 2.2 (m, 2 H, Val a-H's), 3.2 (d, 4 H, cystine methylenes), 
4-6.5 (22 H, Ser methylenes, Ser and cystine a-H's, benzyloxycarbonyl 
and phenacyl methylenes, NH), · 7.4 (s, 10 H, benzyoxycarbonyl 
aromatic), 7.7 (A 2 B2q, 8 H, phenacyl aromatics). (Found: C, 52.31; H, 
5.26; N, 5.83. 
5.7%). 
Attempted lanthionine contraction 
of above hexapeptide ~ 
C, 52.10; H, 5.29, N, 
To hexapeptide ~ (1.1 g, 0.75 mmol) in benzene (10 ml) was added 
hexaethylphosphorus triamide (0.21 g, 0.83 mmol) and the mixture 
stirred at room temp. for 2.5 hr. The reaction mixture was concentrated 
in vacuo and the resulting oil purified on the mplc using 30% acetone 
in hexane as elutant. 1H NMR spectrum of isolated product was 
identical to that of hexapeptide 35. Hence contraction had not 
occurred. 
Synthesis~ N-benzyloxycarbonyl-L-
seryl-L-valine methyl ester 
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To L-valine methyl ester hydrochloride (0.84 g, 5.0 mmol) in 
CH2c1 2 (40 ml) was added triethylamine (0.7 ml, 5.0 mmol) and the 
mixture cooled to 0° in ice-salt bath. N-Benzyloxycarbonyl-L-serine 
(1.2 g, 5.0 mmol) was added followed by N,N'-dicyclohexylcarbodiimide 
(1.13 g, 5.0 mmol) and the reaction mixture was stirred at o° C for 3 
hr and at room temp. overnight. 
The mixture was filtered and the ppt washed well with CH2c1 2• 
Removal of solvent in vacuo led to a white solid, which was dissolved 
in ethyl acetate (50 ml), and the resulting solution filtered to remove 
solid that separated out. The filtrate was washed with sat NaHC03 aq 
(25 ml), 10% citric acid aq (25 ml), sat NaHco 3 aq (25 ml), H2o (25 ml) 
and brine in succession. The organic phase was dried over Na2S04 and 
solvent removed in vacuo to yield a white solid which crystallized from 
ethyl acetate:ether to yield 1.25 g (71%) of dipeptide; m.p. 140-142°; 
tlc (solvent B) Rf: 0.2; 1H NMR (60 MHz, CDC13) 8 0.9 (dd, Val Me's), 
3.8 (s, 3 H, Me ester), 4.4 (m, 2 H, serine methylenes), 5.2 (s, 2 H, 
benzyloxycarbonyl methylenes), 6.1 (bd, 2 H, NH's), 7.5 (s, 5 H, 
benzyloxycarbonyl aromatics). 
Synthesis of N-benzyloxycarbonyl-
0-(p-toluenesulfonyl)-L-seryl-L-
valine methyl ester (61) 
To the above dipeptide, N-benzyloxycarbonyl-L-seryl-L-valine 
methyl ester (1.06 g, 3 mmol), dissolved in pyridine (10 ml) and cooled 
to 0° in ice-salt bath, was added p-toluenesulfonyl chloride (0.63 g, 
3.3 mmol), followed by 4-dimethylamino pyridine (0.04 g, 0.3 mmol). The 
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mixture was kept at -10° for 1.5 hr in cc1 4-dry ice bath and at room 
temp. for an additional hour. 
The solvent was removed in vacuo and ice-water added to the 
residue. The aqueous mixture was extracted with ethyl acetate (50 ml), 
and the organic extract washed quickly with 5% HCl (25 ml) and brine in 
succession. Removal of solvent led to an oil which was purified by 
flash chromatography with 30% acetone in hexane as the eluting solvent 
system to y i e 1 d O. 9 g ( 6 0 % ) of g as an o i 1; t 1 c (so 1 vent B) Rf : 0. 3 5; 
1H NMR (60 MHz, CDC13) o 0.9 (dd, Val Me's), 2.0 (m, lH, Val a-H), 2.5 
(s, 3 H, p-toluenesulfonyl methyl), 3.8 (s, 3 H, Me ester) 4.4 (m, 4 H, 
serine methylenes, et -H's), 5.2 (s, 2 H, benzyloxycarbonyl methylenes), 
7.2-8.0 (9 H, benzyloxycarbonyl, p-toluenesulfonyl aromatics). 
Attempted displacement of g 
with benzyl mercaptan 
To benzyl mercaptan (0.08 ml, 0.65 mmol) in dimethylformamide (5 
ml) was added triethylamine (0.09 ml, 0.65 mmol) and the mixture 
stirred for 5 min. Tosylate g (0.33 g, 0.65 mmol) was added, and the 
mixture stirred at 50° for 3 hr and allowed to stand overnight at room 
temp. 
Solvent was removed in vacuo and ice water (5 ml) was added to the 
residue. The aqueous mixture was extracted with ethyl acetate and the 
organic phase washed with 1 N HCl (5 ml), H2o (5 ml) and brine in 
succession. The organic phase was dried over Na2so4 and solvent 
removed in vacuo to yield an oil. The two major spots on tlc were 
separated by flash chromatography. One corresponded to starting 
tosylate g. The NMR of the other product was consistent for dibenzyl 
disulfide. No displacement product was isolated. 
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Use of sodium methoxide in lieu of triethylamine as base gave 
identical results. 
Displacement of N-benzyloxycarbonyl-
0-(p-toluenes~fonyl)-L-seryl-glycine 
methyl ester with benzyl mercaptan 
To benzyl mercaptan (0.14 ml, 1.22 mmol) in methanol (2.5 ml) was 
added sodium methoxide (0.07 g, 1.22 mmol) and the mixture was stirred 
for 5 min. Solvent was removed in vacuo and the residue was dissolved 
in dimethylformamide (5 ml). N-benzyloxycarbonyl-0-(p-toluene-
sulfonyl)-L-seryl-glycine methyl ester (0.15 g, 0.32 mmol) was added 
and the mixture stirred at room temp. for 1 hr. 
Solvent was removed in vacuo, and to the residue was added ice-
water (5 ml) and 0.1 N HCl (5 ml). The aqueous mixture was extracted 
with ethyl acetate (15 ml) and the organic phase washed with 0.1 N HCl 
(5 ml), H2o (5 ml) and brine in succession, and dried over Na2so4. 
Removal of solvent resulted in an oil which was purified on a gravity 
column with 20% acetone in hexane as the eluting solvent system to 
yield ~08 g (60%) of N-benzyloxycarbonyl-s-benzyl-L-cysteinyl glycine 
methyl ester; tlc (solvent B) Rf 0.41; 1H NMR (60 MHz, CDC13) o 2.9 (d, 
2 H, cysteine methylenes), 3.8 (s, 3 H, methyl ester), 4.1 (d, 2 H, 
Gly methylenes), 4.5 (m, 2 H, Ser methylenes), 5.2 (s, 2 H, benzyloxy-
c a r bony 1 me t h y 1 en e s ) , 5 • 8 ( d , 1 H , NH) , 7 • 0 ( b s , 1 H , NH) , 7 • 4 ( d , 1 0 
H, benzyloxycarbonyl, s-benzyl aromatic). 
Synthesis of tripeptide ~ 
To dipeptide N-benzyloxycarbonyl-0-(N-t-butyloxycarbonyl-L-valyl)-
D-serine p-bromophenacyl ester 45 (0.95 g, 1.5 mmol) was added 
trifluoroacetic acid (5 ml) and the mixture stirred at room temp. for 1 
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hr. The reaction mixture was concentrated on the rotavapor and to the 
residue was added anhyd ether (5 ml). After trituration with ether, 
the solvent was removed in vacuo; this treatment with ether was carried 
out twice, and solvent removed in vacuo to yield a white solid. 
To the white solid in CH2c1 2 (15 ml) was added triethylamine (0.21 
ml, 1.65 mmol) followed by N-t-butyloxycarbonyl-1-serine (0.30 g, 1.5 
mmol). The mixture was cooled to o0 in an ice-salt bath and l-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride (0.29 g, 1.52 mmol) 
was added, followed by 1-hydroxybenzotriazole monohydrate (0.20 g, 1.5 
mmol). The mixture was stirred at o0 for 4 hrs and at room temp. 
overnight. 
The solvent was removed in vacuo and the residue dissolved in 
ethyl acetate (50 ml). The organic phase was washed with H20 (25 ml), 
sat NaHC03 aq (25 ml), 1 N HCl (25 ml), sat NaHC03 aq (25 ml) and sat 
NaCl aq (15 ml) in succession. Drying the organic phase over Na2so4 
and evaporation of solvent led to 1.06 g (98%) of .£1. as a foam; tlc 
(solvent B) Rf 0.2, 1H NMR (60 MHz, CDC13) o 1.0 (dd, 6 H, Val Me's), 
1. 5 ( s , 9 H , Bo c Me 's ) , 2. 2 ( m , 1 H , Va 1 a-H ) , 4- 5 ( 6 H , Se r me t h y 1 e n e s , 
a -H's), 5.2 (s, benzyloxycarbonyl methylenes), 5.4 (s, 2 H, p-
bromophenacyl methylenes) 7.5 (s, 5 H, benzyloxycarbonyl aromatics), 
7.8 (q, 4 H, p-bromophenacyl aromatics). 
Synthesis~ tripeptide mesylate ~ 
To the tripeptide .§1_ (0.2 g, 0.28 mmol) in pyridine (2 ml), cooled 
to 0° in ice-salt bath, was added methanesulfonyl chloride (0.024 ml, 
0.31 mmol). The mixture was stirred at o0 for 1 hr and cooled in the 
refrigerator overnight. 
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Solvent was removed in vacuo, and the residue dissolved in ethyl 
acetate (10 ml). The organic phase was washed with cold 1 N HCl (5 
ml), H2o (5 ml) and dried over Na 2 so4 • Removal of solvent led to 0.22 
g of ~ (96%) as an oil; tlc (solvent B) Rf 0.23, 1H NMR (60 MHz, 
CDCl3) o 0.9 (dd, 6 H, Val Me's), 1.5 (s, 9 H, Boe Me's), 3.0 (s, 3 H, 
methyl), 4-5 (6 H, Ser methylenes a-H's), 5.2 (s, 2 H, 
benzyloxycarbonyl aroma tics), 7 .8 (A2B2 q, 4 H, p-bromophenacyl 
aromatics). 
Attempted displacement of 65 with 
benzyl mercaptan 
To benzyl mercaptan (0.06 ml, 0.6 mmol) in methanol (2 ml) was 
added sodium methoxide (0.03 g, 0.55 mmol) and the mixture stirred for 
5 min. To this mixture was added~ (0.4 g, 0.5 mmol) in dimethyl-
formamide (5 ml) and the mixture stirred at room temp. for 1.5 hr. 
Solvent was removed in vacuo and ice water (10 ml) added to the 
residue. The aqueous phase was extracted with ethyl acetate (10 ml), 
and the organic phase washed with 1 N HCl (5 ml), H2o and brine in 
succession. The organic phase was dried over Na 2 so4 and solvent 
removed in vacuo to yield an oil. The NMR spectrum of the oil 
indicated a mixture of~ and benzyl mercaptan. Tlc showed the major 
spots corresponding to 65 and benzyl mercaptan. 
Synthesis of N-benzyloxycarbonyl-
L-serine-(N-t-butyloxycarbonyl)-
hydrazide ( 66) 
To N-benzyloxycarbonyl-L-serine (1.2 g, 5 mmol) in CH2c1 2 (40 ml) 
was added N-t-butyloxycarbonyl hydrazine (0.73 g, 5.5 mmol) and the 
mixture cooled to 0° in ice-salt bath. N,N'-Dicyclohexycarbodiimide 
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was added, and the mixture stirred at 0° for 3 hr followed by stirring 
at room temp. overnight. 
The reaction mixture was filtered and the ppt washed with CH2c1 2• 
The combined filtrate and washings were concentrated in vacuo and the 
residue dissolved in ethyl acetate (50 ml), when small amounts of solid 
separated. The ethyl acetate extract was filtered, and the filtrate 
washed with sat NaHC03 aq (25 ml), 1 N HCl (25 ml), sat NaHC03 aq (25 
ml) and sat NaCl aq (15 ml) in succession. Drying of the organic phase 
over Na2so4 followed by evaporation of solvent in vacuo resulted in an 
oil. The oil was purified on a silica gel gravity column, to yield 
1.68 g (100%) of (66); tlc (solvent B) Rf 0.34, 1H NMR (60 MHz, CDC13) 
o 1.5 (s, 9 H, Boe Me's), 3.7-4.6 (3 H, Ser methylenes, a-H), 5.2 (s, 2 
H, benzyloxycarbonyl methylenes), 6.2 (d, 1 H, NH), 7.1 (s, 1 H, NH), 
7.4 (s, 5 H, benzyloxycarbonyl aromatics), 8.8 (s, 1 H, NH). 
Synthesis of N-Benzyloxycarbonyl-
0-(p-toluenesulfonyl)-L-serine (N-
t-butyloxycarbonyl) hydrazide (67) 
To!!.!!_ (0.54 g, 1.6 mmol) in pyridine (10 ml), cooled to 0° in ice-
salt bath was added p-toluenesulfonyl chloride (0.32 g, 1.68 mmol) and 
the mixture stirred at o0 for 1 hr, followed by standing overnight in 
the refrigerator. 
The reaction mixture was concentrated in vacuo and ice-water (10 
ml) added to the residue. The aqueous residue was extracted with ethyl 
acetate (25 ml) and the ethyl acetate extract washed quickly with cold 
1 N HCl (15 ml). The organic phase was subsequently washed with H2o 
(10 ml) and brine in succession. After drying the organic phase over 
Na2so4 , solvent was removed in vacuo to yield 0.77 g (97.5 %) of pure 
67 as an oil; tlc (solvent B) Rf 0.51, 1H NMR (60 MHz, CDC13) o 1.5 
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(s, 9 H, Boe Me's), 2.5 (s, 3 H, p-toluenesulfonyl methyl), 4.0-4.9 (3 
H, Ser methylenes, a -H), 5.2 (s, 2 H, benzyloxycarbonyl methylenes), 
6.2 (d, 1 H, NH), 6.9 (s, 1 H, NH), 7-8 (q overlapping s, 9 H, 
benzyloxycarbonyl and p-toluenesulfonyl aromatics), 8.8 (s, 1 H, NH). 
Attempted displacement of!!!.._ 
with benzyl mercaptan 
To benzyl mercaptan (1.04 ml, 1 mmol) in methanol (2 ml) was added 
a solution of sodium methoxide (0.06 g, 1.1 mmol) in methanol (2 ml) 
and the mixture stirred for 5 min. 0.51 g (1 mm) of 67 in 
dimethylformamide (5 ml) was added and the mixture stirred at room 
temp. for 2 hr. 
Solvent was removed in vacuo and ice water (5 ml) was added to the 
residue. The aqueous mixture was extracted with ethyl acetate (10 ml). 
The ethyl acetate phase was washed with 1 N HCl (5 ml), H2o and brine 
in succession. Upon drying over Na2so4 and removal of solvent, an oil 
was obtained. The NMR of this oil was consistent for the product, a 
cyclic intramolecular displacement of the tosylate (see discussion). 
1.5 (s, 9 H, Boe Me's), 3.8 (bd, 2 H, 
methylenes), 5.2 (s, 2 H, benzyloxycarbonyl methylenes) 6.2 (bd, NH), 
7.4 (S, 5 H, benzyloxycarbonyl aromatic), 9.2 (S, 1 H, NH). 
Synthesis~ N,N'-di-t-butyloxy-
carbonyl-L-cystine di-t-butyl 
ester ( 72) 
To a suspension of L-cystine di-t-butyl ester dihydrochloridelOO 
(1.28 g, 3 mmol) in dimethylformamide (30 ml) was added triethylamine 
(0.84 ml, 6 mmol) and the mixture stirred for 5 min. Di-t-butyl 
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dicarbonate (1.46 g, 6.6 mmol) was added and the reaction mixture 
stirred at room temp. for 5 hr. 
Solvent was removed in vacuo and the residue partitioned between 1 
N HCl (50 ml) and ethyl acetate (75 ml). The organic phase was washed 
with 1 N HCl (2 x 25 ml), H2o (25 ml) and brine in succession, and 
dried over Na2so4• Removal of solvent led to an oil which was purified 
on mplc with 10% acetone in hexane as the eluting solvent to yield 1.52 
g ( 91%) of J_J:.. as a white solid; m.p. 9 7-99°; tlc ( solvent B) Rf 0.69; 
1H NMR (60 MHz, CDC13 cS 1.5 (s, 36 H, Boe and t-butyl Me's), 3.2 (d, 4 
H, cystine methylenes), 4.5 (m, 2 H, a-H's), 5.5 (bd, 2 H, NH). 
Synthesis of N-t-butyloxycarbonyl-
L-cysteinet-butyl ester (70) 
To 72 (2.5 g, 4.65 mmol) in 5% acetic acid in ether (65 ml) cooled 
to o0 in ice-salt bath was added zinc dust (18.34 g, 282 mmol) slowly 
in portions over a period of 20 min. The mixture was stirred at o0 for 
2 hr. 
The mixture was filtered and the ppt washed well with acetic acid. 
The combined filtrate and washing was concentrated in vacuo and the 
residue taken up in 1 N HCl (75 ml). The aqueous phase was extracted 
with ethyl acetate (75 ml) and the organic phase washed with sat NaCl 
aq (50 ml). Upon drying over Na2so4 and removal of solvent, 2.51 g 
(100%) of 70 was obtained as an oil; tlc (solvent CHC13) Rf 0.7; 1H NMR 
(60 MHz, CDC13) cS 1.5 (s, 18 H, Boe and t-butyl Me's), 1.9 (d, 1 H, 
SH), 3.0 (dd, 2 H, cysteine methylenes), 4.5 (m, 1 H, a -H), 5.5 (bd, 1 
H, NH). The oil was used in subsequent reactions without further 
purification. 
N,N'-Di-benzyloxycarbonyl-L-cystine 
diethyl ester (73) 
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To L-cystine diethyl ester dihydrochloride (7.38 g, 20 mmol) 
dissolved in H2o (400 ml) and cooled to o0 in ice-salt bath, was added 
NaHco 3 (6.72 g, 80 mmol) slowly, with stirring. To the cold solution 
was added benzyl chloroformate (8.6 ml, 60 mmol) dropwise and the 
reaction mixture stirred at 0° for 1 hr followed by stirring at room 
temp. for 5 hr. 
The reaction mixture was saturated with NaCl and extracted with 
ethyl acetate (4 x 100 ml). The combined organic phase was washed with 
H2o (100 ml) and dried over Na 2 so 4• Removal of solvent in vacuo 
resulted in a white solid which was crystallized from ethyl acetate-
pet. ether to yield 9.8 g (88%) of 21_; m.p. 81-83°; reported m.p. 
86°; 1 0 9 tlc (solvent CHC13 ) Rf 0.21; 
1H NMR (60 MHz, CDC13 ) cS 1.3 (t, 6 
H, Me's of ethyl ester), 3.2 (d, 4 H, cystine methylenes), 4.3 (q, 4H, 
methylenes of ethyl ester), 4.8 (m, 2H, a-H's), 5.2 (s, 4 H, 
benzylo x ycarbonyl methylenes), 5.8 (d, 2 H, NH), 7.5 (s, 10 H, 
be nzyloxycarbonyl aromatics). 
Synthesis of thiol sulfinate !!!_ 
To N,N'-di-benzyloxycarbonyl-L-cystine diethyl ester (5.07 g, 9 
mmol) in CH2c1 2 (150 ml) cooled to o0 in ice-salt bath, was added m-
chloroperbenzoic acid slowly with stirring, when the solution turned 
turbid. The reaction mixture was allowed to warm up to room temp. upon 
which a clear solution resulted. The clear solution was allowed to 
stand overnight at room temp. 
The mixture was washed well with sat NaHC0 3 aq (3 x 50 ml), sat 
NaCl aq (50 ml) and dried over anhyd Na 2 so 4 • Removal of solvent 
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resulted in 5.2 g (100%) of 74 as an oil, which was used for subsequent 
reaction without purification; tlc (solvent B) Rf 0.15. 
Synthesis of N-benzyloxycarbonyl, 
N'-t-butyloxycarbonyl-L-cystine 
ethyl, t-butyl diester (75) 
To the thiolsulfinate !_!!.. (2.31 g, 4 mmol) in benzene (40 ml) was 
added hexaethylphosphorus triamide (0.99 g, 4 mmol) under an atmosphere 
of nitrogen. N-t-Butyloxycarbonyl-L-cysteine t-butyl ester (1.11 g, 4 
mmol) was added, and the mixture stirred under an atmosphere of 
nitrogen for 5 hr. 
Solvent was removed in vacuo and the resulting oil purified on the 
mplc with 10% acetone in hexane as the eluting solvent system to give 
1.23 g (55%) of !.J.. as an oil; tlc (solvent B) Rf 0.31; ·1H NMR (90 MHz, 
CDC13 o 1.3 (t, 3 H, ethyl ester methyl), 1.5 (s, 18 H, Boe and t-butyl 
Me's), 3.2 (t, 4 H, cystine methylenes), 4.3 (q, 2 H, ester 
methylenes), 5.1 (s, 2 H, benzyloxycarbonyl methylenes), 5.4-5.8 (d, 2 
H, NH), 7.4 (s, 5 H, benzyloxycarbonyl aromatics). (Found: C, 54.00; 
H, 7.00; N, 5.05; S, 11.57. c25 H38 o8N2 s2 requires: C, 53.76; H, 6.81; 
N, 5.02; S, 11.47 %). 
Synthesis of lanthionine !..£ 
To cystine !.J.. (0.96 g, 1.74 mmol) in benzene (25 ml) was added 
hexaethylphosphorus triamide (0.47 g, 1.91 mmol), at room temp. under 
an atmosphere of nitrogen, and the reaction mixture stirred for 5 hr. 
Removal of solvent resulted in an oil which was chromatographed on 
the mplc with 10% acetone in hexane as the eluting solvent system to 
yield 0.47 g (52%) of lanthionine 76 as an oil; tlc (solvent B) Rf 
0.31; 1H NMR (60 MHz, CDC13 ) o 1.3 (t, 3 H, ethyl ester methyl), 1.5 
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(s, 18 H, Boe and t-butyl Me's), 3.0 (t, 4 H, lanthionine methylenes), 
4.3 (q, 2 H, ethyl ester methylenes), 5.2 (s, 2 H, benzyloxycarbonyl 
methylenes), 5.4-5.8 (d, 2 H, NH), 7.4 (s, 5 H, benzyloxycarbonyl 
aromatics). (Found: C, 56.90; H, 7.31; N, 5.30; S, 6.09. c 25 H38 o8 N2 s 
requires: C, 57.03; H, 7.22; N, 5.32; S, 6.08 %). 
N,N'-Di-2,2,2-trichloroethyloxy-
carbonyl-L-cystine di-t-butyl 
ester 77 
To 1-cystine di-t-butyl ester dihydrochloride (1.28 g, 3 mmol) in 
H2o (100 ml), cooled to 0° in ice-salt bath, was added NaHC0 3 (1.01 g, 
12 mmol) and the mixture stirred for 5 min. 2,2,2-Trichloroethyl 
chloroformate (1.91 g, 9 mmol) was added to the cold mixture dropwise, 
with stirring. The reaction mixture was stirred at o0 for 2 hr 
followed by s t irring at room temp. for 5 hr. 
The reaction nixture was acidified in cold with 6 N HCl, 
saturated with NaCl and extracted with ethyl acetate (4 x 25 ml). The 
combined organic phase was washed with H2o, sat NaCl aq and dried over 
Na2so4• Removal of solvent led to an oil, which was purified on mplc 
to yield 1.76 g (84%) of!.]_; tlc (solvent B) Rf 0.56, 1H NMR (90 MHz, 
CDC13 ) cS 1.5 (s, 18 H, t-butyl ester Me's), 3.2 (d, 4 H, cystine 
methylenes), 4.6 (m, 2H, a-H's), 4.8 (s, 4 H, trichloroethyloxycarbonyl 
methylenes), 6.0 (d, 2 H, NH's). (Found: C, 34.27; H, 4.38; N, 3.85; 
S, 9.03. C20H30N2S2Cl608 requires: C, 34.14; H, 4.27; N, 3.98; S, 
9.10%). 
Synthesis of thiol sulfinate 78 
To 1.27 g (1.8 mmol) of!.]_ dissolved in CH2c1 2 (40 ml) and cooled 
to 0° in ice-salt bath was added m-chloroperbenzoic acid (0.44 g, 2.16 
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mm61) slowly in portions. The clear solution was turbid after addition 
of the acid. The reaction mixture was allowed to warm up to room temp. 
with stirring, upon which a clear solution resulted. The mixture was 
allowed to stand at room temp. overnight. 
The reaction mixture was washed with sat NaHco 3 aq (3 x 25 ml). 
The combined organic phase was washed with brine, dried over Na2so 4 and 
solvent removed in vacuo to yield 1.12 g(85%) of !..!i as an oil. This oil 
was used without further purification for subsequent reactions; tlc 
(solvent B) Rf: 0.24. 
Synthesis of N-benzyloxycarbonyl-
L-cysteine ethyl ester 
To N,N'-di-benzyloxycarbonyl-L-cystine diethyl ester (1.69 g, 3 
mmol) dissolved in a 5% solution of acetic acid in diethyl ether (100 
ml), and cooled to 0° in ice-salt bath, was added zinc dust (5.81 g, 
180 mmol) slowly, in portions, over a period of 15 min. The mixture 
was stirred at 0° for 2 hr and at room temp. for one hr. 
The reaction mixture was filtered and the ppt washed well with 
acetic acid:ether. The combined filtrate and washings were concentrated 
in vacuo, and the residue dissolved in 1 N HCl (50 ml). The aqueous 
solution was saturated with NaCl and extracted with ethyl acetate (3 x 
25 ml). The organic phase was dried over Na2so 4 to yield 1.69 g (100%) 
of title compound as an oil. This oil was used without further 
purification for subsequent reactions; tlc (solvent A) Rf: 0.3; 1H NMR 
(60 MHz, CDC13) o 1.3 (t, 3 H, ethyl ester Me), 1.9 (d, 1 H, SH), 3.1 
(dd, 2 H, cysteine methylenes, 4.3 (q, 2 H, ester methylenes, 4.8 (m, 1 
H, a-H), 5.2 (s, 2H, benzyloxycarbonyl methylenes), 5.9 (bd, 1 H, NH), 
7.4 (s, 5 H, benzyloxycarbonyl aromatic ). 
Synthesis of N-benzyloxycarbonyl, 
N'-2,2,2-trichloroethyloxycarbonyl-
L-cystine ethyl, t-butyl diester (79) 
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To a solution of thiol sulfinate ~ (2.01 g, 2.8 mmol) in benzene 
(40 ml), through which nitrogen gas had been bubbled through for 5 min, 
was added hexaethylphosphorus triamide (O.72 g, 3.0 mmol) at room temp. 
under nitrogen, followed by N-benzyloxycarbonyl-L-cysteine ethyl ester 
(O.84 g, 4 mmol), and the mixture stirred at room temperature for 8 hr. 
The solvent was removed in vacuo and the resulting oil purified on the 
mplc with 10% acetone in hexane as elutant to yield 0.90 g (54%) of ].J_ 
as an oil; tlc (solvent hexane-acetone, 9:1) Rf 0.2; 1H NMR (60 MHz, 
CDC13 ) o 1.3 (t, 3 H, ethyl ester Me), 1.5 (s, 9 H, t-butylester Me), 
3.2 (d, 2 H, cystine methylenes), 4.3 (q, 2 H, ethyl ester methylenes), 
4.6 (m, 2 H, a-H's), 4.8 (s, 2 H, trichloroethyloxycarbonyl methylenes), 
5.2 (s, 2 H, benzyloxycarbonyl methylenes), 5.9 (dd, 2 H, NH's), 7.4 
(s, 5 H, benzyloxycarbonyl aromatics). (Found: C, 43.25; H, 4.96; N, 
4.54; S, 9.63. c 23 H31 N20 8 c1 3 s2 requires: C, 43.57; H, 4.89; N, 4.42; 
s, 10.10%.) 
Synthesis Ei_ lanthionine ~ 
To a solution of ].J_ (O.33 g, 0.54 mmol) in benzene (15 ml) was 
added hexaethylphosphorus triamide (0.34 g, 1.36 mmol) dropwise, with 
stirring, under nitrogen. The reaction mixture was stirred at room 
temp. overnight, and evaporated in vacuo to an oil. The oil was 
purified on the mplc with 10% acetone in hexane as the eluting solvent, 
to yield 0.18 g (58%) of~ as an oil; tlc (solvent hexane-acetone, 
9:1) Rf: 0.22; 1H NMR (90 MHz, CDC13 ) 0 1.3 (t, 3 H, ethyl ester Me), 
1.5 (s, 9 H, t-butyl ester Me), 3.0 (d, 2 H, lanthionine methylenes), 
4.2 (q, 2 H, ethyl ester methylenes), 4.6 (m, 2 H, a-H's), 4.8 (s, 2 H, 
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trichloroethyloxycarbonyl methylenes), 5.2 (s, 2 H, benzyloxycarbonyl 
methylenes), 5.9 (dd, 2 H, NH's), 7.4 (s, 5 H, benzyloxycarbonyl 
aromatics). (Found: C, 47.16; H, 5.27; N, 4.75; S, 5.59. 
c 23 H31 N2 0 8 c1 3 requires: C, 45.88; H, 5.15; N, 4.66; S, 5.32%). Two 
attempts to obtain satisfactory analysis for 80 resulted in% C found 
to be higher than the calculated value. 
Synthesis~ N-2,2,2-trichloro-
ethyloxycarbonyl-L-cysteine 
t-butyl ester (86) 
To !.l_ (0.37 g, 0.53 mmol) in 90% methanol aq (5 ml) was added tri-
n-butyl phosphine (0.312 g, 1.05 mmol) and the reaction mixture was 
stirred at room temp. for 5 hr. The solvent was removed in vacuo and 
the residue triturated with ether (10 ml). Removal of ether led to an 
oil which was purified on a silica gel gravity column with 5% acetone 
in hexane as the elutant. Compound~ was obtained, 0.33 g (89%), as 
an oil; tlc (solvent hexane-acetone, 9:1), Rf 0.3, 1H NMR (60 MHz, 
CDC1 3) o 1.5 (s, 9 H, t-butyl ester Me's), 1.9 (d, 1 H, SH), 3.2 (dd, 2 
H, cysteine me thylenes), 4.8 ( s, 2 H, trichloroethyloxycarbonyl 
methylenes). 
Alternate method of synthesis 
of 79 
To thiolsulfinate !..!:_ (1.03 g, 1.78 mmol) in benzene (20 ml) was 
added hexaethylphosphorus triamide (0.44 g, 1.78 mmol) under nitrogen. 
N-2,2,2-trichloroethyloxycarbonyl-L-cysteine t-butyl ester was added, 
and the mixture stirred under N2 for 6 hr. 
Solvent was removed in vacuo and the resulting oil purified on the 
mplc with 10% acetone in hexane to yield 0.70 g (65%) of 22_ as an oil. 
This oil was identical to the one prepared by the previous method. 
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Abbreviations 
The abbreviations used in this dissertation are as follow: 
Acrn: 
Barn: 
Boe: 
Bpa: 
DCC: 
EDC: 
HOBT: 
Tee: 
Toe: 
Qxc: 
Z: 
Acetarnidornethyl 
Benzarnidornethyl 
t-Butyloxycarbonyl 
p-Brornophenacyl 
N,N'-dicyclohexylcarbodiirnide 
l-Ethyl-3-(3-dirnethylaminopropyl)carbodiirnide hydrochloride 
1-Hydroxybenzotriazole 
2,2,2-Trichloroethyl 
2,2,2-Trichloroethyloxycarbonyl 
Quinoxaline-2-carbonyl 
Benzyloxycarbonyl 
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